| Prescription ID | TCMF5392 |
| Pinyin Name | Wan Ying Cha |
| Chinese Name | 万应茶 |
| English Name | Wan Ying Tea |
| Function Description | 积滞, 腹痛, å‘•å, 腹泻, 腹胀, 痢疾, ç±»éœä¹± |
| Indications | Dysentery disorder, Abdominal pain disorder, Severe vomiting and diarrhoea disorder, Diarrhea, Dyspepsia, Cholera, Dysentery |
| Disease ICD-11 Category |
SA56 [Dysentery disorder (TM1), 痢疾 (TM1)
]; SA58 [Abdominal pain disorder (TM1), 腹痛 (TM1) ]; SD92 [Severe vomiting and diarrhoea disorder (TM1), éœä¹± (TM1) ]; ME05.1 [Diarrhoea, 腹泻 ]; MD92 [Dyspepsia, 消化ä¸è‰¯ ]; 1A00 [Cholera, éœä¹± ]; 1A40.Z [Infectious gastroenteritis or colitis without specification of infectious agent, æœªç‰¹æŒ‡æ„ŸæŸ“æ€§ç—…åŽŸä½“çš„æ„ŸæŸ“æ€§èƒƒè‚ ç‚Žæˆ–ç»“è‚ ç‚Ž ]; |
| Human Tissues Associated with Indication | Intestine, Stomach, Spleen |
| Reference | CFDA |
| Reference Book/link | http://samr.cfda.gov.cn/WS01/CL0001/ |
| Component ID | Latin Name | Chinese Name | Component Quantity | Barcode |
|---|---|---|---|---|
| TCMH363 | Rheum officinale | 大黄 | TCMH363 | ITSAJ4685-14 |
| TCMH1533 | Saussurea lappa | 木香 | TCMH1533 | |
| TCMH512 | Fructus amomi rotundus | 豆蔻 | TCMH512 | |
| TCMH243 | Pericarpium citri reticulatae | 陈皮 | TCMH243 | |
| TCMH890 | Cortex magnoliae officinalis | 厚朴 | TCMH890 | ITSAM1591-14 |
| TCMH728 | Pogostemon cablin | 广藿香 | TCMH728 | ITSAJ4146-14 |
| TCMH188 | Mentha haplocalyx | è–„è· | TCMH188 | HM595443 |
| TCMH1518 | Chaenomeles sinensis | 木瓜 | TCMH1518 | GBVJ2053-11, GBVJ2052-11 |
| TCMH1665 | Notopterygium incisum | 羌活 | TCMH1665 | JF755946 |
| TCMH1656 | Angelica decursiva | å‰èƒ¡ | TCMH1656 | ITSAN4164-14 |
| TCMH120 | Atractylodes macrocephala | 白术 | TCMH120 | ITSAN4430-14 |
| TCMH1499 | Changium smyrnioides | æ˜Žå…šå‚ | TCMH1499 | |
| TCMH486 | Syzygium aromaticum | ä¸é¦™ | TCMH486 | GBVI185-11 |
| TCMH606 | Wolfiporia cocos | 茯苓 | TCMH606 | GBPOL314-13 |
| TCMH182 | Areca catechu | 槟榔 | TCMH182 | ITSAA732-14 |
| TCMH45 | Lablab purpureus | 白æ‰è±† | TCMH45 | ITSAM881-14 |
| TCMH1080 | Platycodon grandiflorum | 桔梗 | TCMH1080 | ITSAJ4293-14 |
| TCMH118 | Angelica dahurica | 白芷 | TCMH118 | ITSAK3312-14 |
| TCMH130 | Pinellia ternata | åŠå¤ | TCMH130 | GBVT1123-13, GBVY1693-14 |
| TCMH211 | Atractylodes lancea | è‹æœ¯ | TCMH211 | ITSAN4439-14 |
| TCMH628 | Glycyrrhiza uralensis | ç”˜è‰ | TCMH628 | ITSAM892-14 |
| TCMH226 | Camellia sinensis | èŒ¶å¶ | TCMH226 | ITSAG2924-14 |
| TCMH2066 | Santalum album | 檀香 | TCMH2066 | ITSAJ4584-14 |
| TCMH2722 | Perilla frutescens var. arguta | ç´«è‹å¶ | TCMH2722 | ITSAF2620-14 |
| TCMH2276 | Elsholtzia splendens | 香薷 | TCMH2276 | ITSAM4603-14 |
| TCMH2618 | Citrus aurantium | 枳壳 | TCMH2618 | ITSAA1279-14 |
| TCMH2581 | Alisma orientale | 泽泻 | TCMH2581 | KC573871 |
| TCMH1742 | Cinnamomum cassia | 肉桂 | TCMH1742 | GQ255631 |
| TCMH1848 | Crataegus pinnatifida | 山楂 | TCMH1848 | ITSAH1684-14 |
| TCMH1741 | Myristica fragrans | 肉豆蔻 | TCMH1741 | GENG137-13, GBVH1657-11 |
| TCMH2295 | fructus foeniculi | å°èŒ´é¦™ | TCMH2295 | |
| TCMH1803 | Amomum villosum | ç ‚ä» | TCMH1803 | ITSAD521-14 |
| TCMH2671 | Polyporus umbellatus | 猪苓 | TCMH2671 | NOBAS3307-16 |
| TCMH2265 | Cyperus rotundus | 香附 | TCMH2265 | GENG1049-15 |
| Target ID | Gene Symbol | Target Name | Target Class | Uniprot ID |
|---|---|---|---|---|
| TCMT100 | TTR | Transthyretin | Unclassified | P02766 |
| TCMT101 | PTPN1 | Protein-tyrosine phosphatase 1B | Hydrolase | P18031 |
| TCMT102 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | Hydrolase | P24666 |
| TCMT103 | PTPRF | Receptor-type tyrosine-protein phosphatase F (LAR) | Hydrolase | P10586 |
| TCMT107 | GRIK2 | Glutamate receptor ionotropic kainate 2 | Ion channel | Q13002 |
| TCMT109 | GRIA2 | Glutamate receptor ionotropic, AMPA 2 | Ion channel | P42262 |
| TCMT110 | GRIA4 | Glutamate receptor ionotropic, AMPA 4 | Ion channel | P48058 |
| TCMT111 | GRIK5 | Glutamate receptor ionotropic kainate 5 | Ion channel | Q16478 |
| TCMT112 | ADORA3 | Adenosine A3 receptor | GPCR | P0DMS8 |
| TCMT114 | CNR2 | Cannabinoid CB2 receptor | GPCR | P34972 |
| TCMT115 | CNR1 | Cannabinoid CB1 receptor | GPCR | P21554 |
| TCMT126 | TERT | Telomerase reverse transcriptase | Transferase | O14746 |
| TCMT127 | PARP1 | Poly [ADP-ribose] polymerase-1 | Transferase | P09874 |
| TCMT128 | TNKS2 | Tankyrase-2 | Transferase | Q9H2K2 |
| TCMT129 | TNKS | Tankyrase-1 | Transferase | O95271 |
| TCMT13 | APEX1 | DNA-(apurinic or apyrimidinic site) lyase | Lyase | P27695 |
| TCMT130 | ALOX5 | Arachidonate 5-lipoxygenase | Oxidoreductase | P09917 |
| TCMT131 | ACHE | Acetylcholinesterase | Hydrolase | P22303 |
| TCMT133 | CA1 | Carbonic anhydrase I | Lyase | P00915 |
| TCMT134 | CA2 | Carbonic anhydrase II | Lyase | P00918 |
| TCMT135 | CA14 | Carbonic anhydrase XIV | Lyase | Q9ULX7 |
| TCMT136 | CA12 | Carbonic anhydrase XII | Lyase | O43570 |
| TCMT137 | CA9 | Carbonic anhydrase IX | Lyase | Q16790 |
| TCMT138 | CA7 | Carbonic anhydrase VII | Lyase | P43166 |
| TCMT142 | CA4 | Carbonic anhydrase IV | Lyase | P22748 |
| TCMT150 | RORC | Nuclear receptor ROR-gamma | Nuclear receptor | P51449 |
| TCMT151 | PRKCA | Protein kinase C alpha | Kinase | P17252 |
| TCMT152 | PRKCB | Protein kinase C beta | Kinase | P05771 |
| TCMT153 | PRKCG | Protein kinase C gamma | Kinase | P05129 |
| TCMT154 | PRKCD | Protein kinase C delta | Kinase | Q05655 |
| TCMT155 | PRKCE | Protein kinase C epsilon | Kinase | Q02156 |
| TCMT156 | CYP19A1 | Cytochrome P450 19A1 | Oxidoreductase | P11511 |
| TCMT159 | TYR | Tyrosinase | Oxidoreductase | P14679 |
| TCMT160 | HTR7 | Serotonin 7 (5-HT7) receptor | GPCR | P34969 |
| TCMT161 | HCAR2 | Hydroxycarboxylic acid receptor 2 | GPCR | Q8TDS4 |
| TCMT162 | UGT1A1 | UDP-glucuronosyltransferase 1-1 | Transferase | P22309 |
| TCMT164 | PTGS1 | Cyclooxygenase-1 | Oxidoreductase | P23219 |
| TCMT17 | POLB | DNA polymerase beta | Transferase | P06746 |
| TCMT171 | PTPN6 | Protein-tyrosine phosphatase 1C | Hydrolase | P29350 |
| TCMT174 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | Oxidoreductase | P28845 |
| TCMT189 | DUSP3 | Dual specificity protein phosphatase 3 | Hydrolase | P51452 |
| TCMT190 | PTPN2 | T-cell protein-tyrosine phosphatase | Hydrolase | P17706 |
| TCMT2 | MAPT | Microtubule-associated protein tau | Unclassified | P10636 |
| TCMT206 | CYP2A6 | Cytochrome P450 2A6 | Oxidoreductase | P11509 |
| TCMT207 | BACE1 | Beta-secretase 1 | Protease | P56817 |
| TCMT209 | HSD11B2 | 11-beta-hydroxysteroid dehydrogenase 2 | Oxidoreductase | P80365 |
| TCMT210 | CES2 | Carboxylesterase 2 | Hydrolase | O00748 |
| TCMT212 | SRC | Tyrosine-protein kinase SRC | Kinase | P12931 |
| TCMT213 | SLC22A1 | Solute carrier family 22 member 1 | Transporter | O15245 |
| TCMT215 | CYP1A1 | Cytochrome P450 1A1 | Oxidoreductase | P04798 |
| TCMT217 | CYP2C8 | Cytochrome P450 2C8 | Oxidoreductase | P10632 |
| TCMT219 | CYP1A2 | Cytochrome P450 1A2 | Oxidoreductase | P05177 |
| TCMT221 | ABCB11 | Bile salt export pump | Transporter | O95342 |
| TCMT223 | AKR1B1 | Aldose reductase | Oxidoreductase | P15121 |
| TCMT23 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | Hydrolase | P05186 |
| TCMT231 | GBA2 | Beta-glucosidase | Hydrolase | Q9HCG7 |
| TCMT232 | ABCB1 | P-glycoprotein 1 | Transporter | P08183 |
| TCMT233 | PTPN11 | Protein-tyrosine phosphatase 2C | Hydrolase | Q06124 |
| TCMT236 | ESR2 | Estrogen receptor beta | Nuclear receptor | Q92731 |
| TCMT239 | PIM1 | Serine/threonine-protein kinase PIM1 | Kinase | P11309 |
| TCMT249 | CDK6 | Cyclin-dependent kinase 6 | Kinase | Q00534 |
| TCMT257 | CYP1B1 | Cytochrome P450 1B1 | Oxidoreductase | Q16678 |
| TCMT260 | FLT3 | Tyrosine-protein kinase receptor FLT3 | Kinase | P36888 |
| TCMT261 | DAPK1 | Death-associated protein kinase 1 | Kinase | P53355 |
| TCMT268 | CYP2A13 | Cytochrome P450 2A13 | Oxidoreductase | Q16696 |
| TCMT280 | AKR1B10 | Aldo-keto reductase family 1 member B10 | Oxidoreductase | O60218 |
| TCMT289 | TBXAS1 | Thromboxane-A synthase | Isomerase | P24557 |
| TCMT292 | CHRM1 | Muscarinic acetylcholine receptor M1 | GPCR | P11229 |
| TCMT293 | CHRM2 | Muscarinic acetylcholine receptor M2 | GPCR | P08172 |
| TCMT295 | MMP1 | Matrix metalloproteinase-1 | Hydrolase | P03956 |
| TCMT296 | ADORA1 | Adenosine A1 receptor | GPCR | P30542 |
| TCMT297 | FABP4 | Fatty acid binding protein adipocyte | Unclassified | P15090 |
| TCMT298 | FABP3 | Fatty acid binding protein muscle | Hydrolase | P05413 |
| TCMT3 | ALOX15 | Arachidonate 15-lipoxygenase | Oxidoreductase | P16050 |
| TCMT30 | PTGS2 | Cyclooxygenase-2 | Oxidoreductase | P35354 |
| TCMT302 | HMGCR | HMG-CoA reductase | Oxidoreductase | P04035 |
| TCMT304 | MMP14 | Matrix metalloproteinase 14 | Hydrolase | P50281 |
| TCMT306 | MMP2 | Matrix metalloproteinase-2 | Hydrolase | P08253 |
| TCMT309 | SLC22A2 | Solute carrier family 22 member 2 | Transporter | O15244 |
| TCMT310 | SLC47A2 | Multidrug and toxin extrusion protein 2 | Transporter | Q86VL8 |
| TCMT311 | SLC47A1 | Multidrug and toxin extrusion protein 1 | Transporter | Q96FL8 |
| TCMT313 | HTR2B | Serotonin 2b (5-HT2b) receptor | GPCR | P41595 |
| TCMT314 | HTR2C | Serotonin 2c (5-HT2c) receptor | GPCR | P28335 |
| TCMT315 | HTR6 | Serotonin 6 (5-HT6) receptor | GPCR | P50406 |
| TCMT318 | HKDC1 | Putative hexokinase HKDC1 | Transferase | Q2TB90 |
| TCMT321 | MMP9 | Matrix metalloproteinase 9 | Hydrolase | P14780 |
| TCMT322 | MMP13 | Matrix metalloproteinase 13 | Hydrolase | P45452 |
| TCMT327 | TRPV1 | Vanilloid receptor | Ion channel | Q8NER1 |
| TCMT329 | NQO2 | Quinone reductase 2 | Oxidoreductase | P16083 |
| TCMT337 | XPO1 | Exportin-1 | Unclassified | O14980 |
| TCMT344 | AOX1 | Aldehyde oxidase | Oxidoreductase | Q06278 |
| TCMT354 | AURKA | Serine/threonine-protein kinase Aurora-A | Kinase | O14965 |
| TCMT36 | HTR1A | Serotonin 1a (5-HT1a) receptor | GPCR | P08908 |
| TCMT369 | IGF1R | Insulin-like growth factor I receptor | Kinase | P08069 |
| TCMT37 | HTR2A | Serotonin 2a (5-HT2a) receptor | GPCR | P28223 |
| TCMT370 | KDR | Vascular endothelial growth factor receptor 2 | Kinase | P35968 |
| TCMT374 | AURKB | Serine/threonine-protein kinase Aurora-B | Kinase | Q96GD4 |
| TCMT377 | INSR | Insulin receptor | Kinase | P06213 |
| TCMT384 | GRK6 | G protein-coupled receptor kinase 6 | Kinase | P43250 |
| TCMT388 | AXL | Tyrosine-protein kinase receptor UFO | Kinase | P30530 |
| TCMT401 | MET | Hepatocyte growth factor receptor | Kinase | P08581 |
| TCMT418 | EPHB4 | Ephrin type-B receptor 4 | Kinase | P54760 |
| TCMT422 | CAMK2B | CaM kinase II beta | Kinase | Q13554 |
| TCMT423 | EGFR | Epidermal growth factor receptor erbB1 | Kinase | P00533 |
| TCMT436 | NUAK1 | NUAK family SNF1-like kinase 1 | Kinase | O60285 |
| TCMT44 | GLO1 | Glyoxalase I | Lyase | Q04760 |
| TCMT445 | NEK2 | Serine/threonine-protein kinase NEK2 | Kinase | P51955 |
| TCMT45 | APP | Beta amyloid A4 protein | Unclassified | P05067 |
| TCMT457 | FLT4 | Vascular endothelial growth factor receptor 3 | Kinase | P35916 |
| TCMT46 | F3 | Coagulation factor III | Unclassified | P13726 |
| TCMT462 | NEK6 | Serine/threonine-protein kinase NEK6 | Kinase | Q9HC98 |
| TCMT47 | BCL2 | Apoptosis regulator Bcl-2 | Ion channel | P10415 |
| TCMT479 | AKT1 | Serine/threonine-protein kinase AKT | Kinase | P31749 |
| TCMT48 | SCN5A | Sodium channel protein type V alpha subunit | Ion channel | Q14524 |
| TCMT484 | PLK1 | Serine/threonine-protein kinase PLK1 | Kinase | P53350 |
| TCMT502 | TEK | Tyrosine-protein kinase TIE-2 | Kinase | Q02763 |
| TCMT506 | PTK2B | Protein tyrosine kinase 2 beta | Kinase | Q14289 |
| TCMT508 | SYK | Tyrosine-protein kinase SYK | Kinase | P43405 |
| TCMT536 | PDGFRB | Platelet-derived growth factor receptor beta | Kinase | P09619 |
| TCMT551 | CHRM4 | Muscarinic acetylcholine receptor M4 | GPCR | P08173 |
| TCMT558 | TOP2A | DNA topoisomerase II alpha | Isomerase | P11388 |
| TCMT559 | ADRB2 | Beta-2 adrenergic receptor | GPCR | P07550 |
| TCMT560 | F10 | Coagulation factor X | Unclassified | P00742 |
| TCMT561 | NT5E | 5'-nucleotidase | Hydrolase | P21589 |
| TCMT563 | CDC25B | Dual specificity phosphatase Cdc25B | Hydrolase | P30305 |
| TCMT567 | DNMT1 | DNA (cytosine-5)-methyltransferase 1 | Transferase | P26358 |
| TCMT571 | ADORA2B | Adenosine A2b receptor | GPCR | P29275 |
| TCMT591 | ESRRA | Estrogen-related receptor alpha | Nuclear receptor | P11474 |
| TCMT592 | XDH | Xanthine dehydrogenase | Oxidoreductase | P47989 |
| TCMT597 | SLC28A3 | Solute carrier family 28 member 3 | Transporter | Q9HAS3 |
| TCMT599 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Transferase | P61088 |
| TCMT608 | SLC22A3 | Solute carrier family 22 member 3 | Transporter | O75751 |
| TCMT614 | EGLN1 | Egl nine homolog 1 | Oxidoreductase | Q9GZT9 |
| TCMT626 | BRAF | Serine/threonine-protein kinase B-raf | Kinase | P15056 |
| TCMT63 | PPARA | Peroxisome proliferator-activated receptor alpha | Nuclear receptor | Q07869 |
| TCMT636 | POLA1 | DNA polymerase alpha subunit | Transferase | P09884 |
| TCMT637 | SIRT3 | NAD-dependent deacetylase sirtuin 3 | Hydrolase | Q9NTG7 |
| TCMT638 | SIRT2 | NAD-dependent deacetylase sirtuin 2 | Hydrolase | Q8IXJ6 |
| TCMT645 | HTR1E | Serotonin 1e (5-HT1e) receptor | GPCR | P28566 |
| TCMT646 | HTR5A | Serotonin 5a (5-HT5a) receptor | GPCR | P47898 |
| TCMT65 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | Oxidoreductase | P14061 |
| TCMT653 | GRM1 | Metabotropic glutamate receptor 1 | GPCR | Q13255 |
| TCMT654 | GRM5 | Metabotropic glutamate receptor 5 | GPCR | P41594 |
| TCMT655 | GRM2 | Metabotropic glutamate receptor 2 | GPCR | Q14416 |
| TCMT656 | GRM3 | Metabotropic glutamate receptor 3 | GPCR | Q14832 |
| TCMT657 | GRM4 | Metabotropic glutamate receptor 4 | GPCR | Q14833 |
| TCMT66 | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | Oxidoreductase | P37059 |
| TCMT660 | GRM8 | Metabotropic glutamate receptor 8 | GPCR | O00222 |
| TCMT664 | SLC1A1 | Excitatory amino acid transporter 3 | Transporter | P43005 |
| TCMT675 | ADRB1 | Beta-1 adrenergic receptor | GPCR | P08588 |
| TCMT683 | MIF | Macrophage migration inhibitory factor | Isomerase | P14174 |
| TCMT689 | TGM2 | Protein-glutamine gamma-glutamyltransferase | Transferase | P21980 |
| TCMT690 | HDAC3 | Histone deacetylase 3 | Hydrolase | O15379 |
| TCMT707 | ADORA2A | Adenosine A2a receptor | GPCR | P29274 |
| TCMT709 | SLC28A2 | Sodium/nucleoside cotransporter 2 | Transporter | O43868 |
| TCMT710 | SLC28A1 | Sodium/nucleoside cotransporter 1 | Transporter | O00337 |
| TCMT721 | HSPA1A | Heat shock 70 kDa protein 1 | Unclassified | P0DMV8 |
| TCMT726 | BCR | Bcr/Abl fusion protein | Kinase | P11274 |
| TCMT729 | PIK3CA | PI3-kinase p110-alpha subunit | Transferase | P42336 |
| TCMT730 | PIK3CB | PI3-kinase p110-beta subunit | Transferase | P42338 |
| TCMT734 | MMP12 | Matrix metalloproteinase 12 | Hydrolase | P39900 |
| TCMT737 | APOBEC3G | DNA dC->dU-editing enzyme APOBEC-3G | Unclassified | Q9HC16 |
| TCMT739 | GPR35 | G-protein coupled receptor 35 | GPCR | Q9HC97 |
| TCMT740 | PIK3CG | PI3-kinase p110-gamma subunit | Transferase | P48736 |
| TCMT747 | ABCG2 | ATP-binding cassette sub-family G member 2 | Transporter | Q9UNQ0 |
| TCMT751 | DYRK1A | Dual-specificity tyrosine-phosphorylation regulated kinase 1A | Kinase | Q13627 |
| TCMT752 | CSNK2A1 | Casein kinase II alpha | Kinase | P68400 |
| TCMT753 | SMAD3 | Mothers against decapentaplegic homolog 3 | Unclassified | P84022 |
| TCMT755 | PLK4 | Serine/threonine-protein kinase PLK4 | Kinase | O00444 |
| TCMT756 | MAP3K8 | Mitogen-activated protein kinase kinase kinase 8 | Kinase | P41279 |
| TCMT781 | CYP2E1 | Cytochrome P450 2E1 | Oxidoreductase | P05181 |
| TCMT784 | AVPR2 | Vasopressin V2 receptor | GPCR | P30518 |
| TCMT785 | CXCR1 | Interleukin-8 receptor A | GPCR | P25024 |
| TCMT786 | CCR4 | C-C chemokine receptor type 4 | GPCR | P51679 |
| TCMT791 | PKN1 | Protein kinase N1 | Kinase | Q16512 |
| TCMT793 | PYGL | Liver glycogen phosphorylase | Transferase | P06737 |
| TCMT8 | KDM4E | Lysine-specific demethylase 4D-like | Oxidoreductase | B2RXH2 |
| TCMT808 | FABP5 | Fatty acid binding protein epidermal | Unclassified | Q01469 |
| TCMT809 | FABP2 | Fatty acid binding protein intestinal | Unclassified | P12104 |
| TCMT810 | TLR2 | Toll-like receptor 2 | Unclassified | O60603 |
| TCMT815 | HTR1D | Serotonin 1d (5-HT1d) receptor | GPCR | P28221 |
| TCMT816 | HTR1B | Serotonin 1b (5-HT1b) receptor | GPCR | P28222 |
| TCMT817 | HTR4 | Serotonin 4 (5-HT4) receptor | GPCR | Q13639 |
| TCMT82 | ESR1 | Estrogen receptor alpha | Nuclear receptor | P03372 |
| TCMT822 | FUT7 | Alpha-(1,3)-fucosyltransferase 7 | Transferase | Q11130 |
| TCMT83 | CD38 | Lymphocyte differentiation antigen CD38 | Unclassified | P28907 |
| TCMT910 | ESRRB | Estrogen-related receptor beta | Nuclear receptor | O95718 |
| Target ID | Target Name |
|---|---|
| TCMT1170 | Enterobacter cloacae |
| TCMT1175 | Human immunodeficiency virus |
| TCMT1176 | Streptococcus pneumoniae |
| TCMT1178 | Actinomyces viscosus |
| TCMT1179 | Escherichia coli ATCC 8739 |
| TCMT1181 | Mycobacterium tuberculosis H37Ra |
| TCMT1182 | Streptococcus sanguinis |
| TCMT1183 | Candida albicans SC5314 |
| TCMT1186 | Plasmodium yoelii yoelii |
| TCMT1187 | Enterococcus faecalis ATCC 29212 |
| TCMT1189 | Pseudomonas fluorescens |
| TCMT1190 | Plasmodium falciparum (isolate FcB1 / Columbia) |
| TCMT1201 | Staphylococcus epidermidis ATCC 12228 |
| TCMT1207 | Legionella pneumophila |
| TCMT1208 | Escherichia coli K12 |
| TCMT1209 | Staphylococcus haemolyticus |
| TCMT1210 | Streptococcus sobrinus |
| TCMT1211 | Fusobacterium nucleatum |
| TCMT1212 | Verticillium dahliae |
| TCMT1213 | Neisseria gonorrhoeae |
| TCMT1214 | Enterococcus faecium |
| TCMT1215 | Pseudomonas aeruginosa PAO1 |
| TCMT1218 | Staphylococcus aureus |
| TCMT1219 | Enterococcus |
| TCMT1221 | Human herpesvirus 4 |
| TCMT1222 | Plasmodium falciparum D6 |
| TCMT1223 | Staphylococcus epidermidis |
| TCMT1224 | Proteus mirabilis |
| TCMT1226 | Klebsiella pneumoniae |
| TCMT1227 | Streptococcus |
| TCMT1229 | Enterococcus faecalis |
| TCMT1231 | Human herpesvirus 1 strain KOS |
| TCMT1232 | Pseudomonas aeruginosa |
| TCMT1234 | Bacillus coagulans |
| TCMT1235 | Clostridium sporogenes |
| TCMT1236 | Mycobacterium bovis |
| TCMT1237 | Mycobacterium kansasii |
| TCMT1238 | Mycobacterium xenopi |
| TCMT1239 | Mycobacterium marinum |
| TCMT1243 | Aspergillus flavus |
| TCMT1245 | Phytophthora cactorum |
| TCMT1246 | Escherichia coli |
| TCMT1247 | Human herpesvirus 1 |
| TCMT1248 | Hepatitis C virus |
| TCMT1249 | Dengue virus 2 |
| TCMT1251 | Candida albicans |
| TCMT1253 | Penicillium chrysogenum |
| TCMT1255 | Human immunodeficiency virus 1 |
| TCMT1257 | Colletotrichum lagenarium |
| TCMT1283 | Human enterovirus 71 |
| TCMT1284 | Penicillium expansum |
| TCMT1286 | Bacillus cereus |
| TCMT1294 | Human parainfluenza virus 3 |
| TCMT1312 | Enterococcus durans |
| TCMT1318 | Human T-lymphotropic virus 1 |
| TCMT1321 | Staphylococcus hominis |
| TCMT1343 | Staphylococcus simulans |
| TCMT1344 | Staphylococcus sciuri |
| TCMT1346 | Helicobacter pylori |
| TCMT1349 | Helicobacter pylori SS1 |
| TCMT1354 | Streptococcus mutans UA159 |
| TCMT1361 | Neisseria meningitidis |
| TCMT1370 | Prevotella melaninogenica |
| TCMT1382 | Plasmodium falciparum (isolate K1 / Thailand) |
| TCMT1390 | Human herpesvirus 2 strain G |
| TCMT1393 | Vibrio sp. |
| TCMT1408 | Colletotrichum gloeosporioides |
| TCMT1412 | Salmonella typhimurium |
| TCMT1438 | Plasmodium falciparum |
| TCMT1439 | Mycobacterium smegmatis |
| TCMT1442 | Leishmania donovani |
| TCMT1443 | Leishmania amazonensis |
| TCMT1444 | Fusarium oxysporum |
| TCMT1447 | Respiratory syncytial virus |
| TCMT1448 | Enterobacter aerogenes |
| TCMT1449 | Influenza A virus |
| TCMT1450 | Plasmodium falciparum 3D7 |
| TCMT1454 | Bacillus subtilis |
| TCMT1455 | Mycobacterium tuberculosis H37Rv |
| TCMT1457 | Leishmania major |
| TCMT1458 | Filobasidiella neoformans |
| TCMT1462 | Streptococcus mutans |
| TCMT1463 | Mycobacterium tuberculosis |
| TCMT1464 | Hepatitis B virus |
| TCMT1465 | Entamoeba histolytica |
| GO Term | GO Name | Enriched Genes | Log10 Adjusted P-value |
|---|---|---|---|
| [BP] GO:0065008 | regulation of biological quality | ABCB1, ABCG2, ACHE, ADORA1, ADORA2A, ADRB1, ADRB2, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CHRM1, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, F10, F3, FABP3, FABP4, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR4, HTR7, INSR, KDR, MET, MIF, PIK3CA, PIK3CB, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PTGS1, PTGS2, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TRPV1, XDH | 24.4862 |
| [BP] GO:0042221 | response to chemical | ABCB1, ABCG2, ADORA2A, ADRB2, AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSD11B2, HSD17B2, HSPA1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, IGF1R, INSR, KDR, MMP2, MMP9, PIK3CA, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, RORC, SMAD3, SRC, TEK, TERT, TRPV1, TYR | 16.9969 |
| [BP] GO:0007187 | None | ADORA1, ADORA2A, ADRB1, ADRB2, CHRM1, CHRM2, CHRM4, CNR1, CNR2, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1D, HTR1E, HTR4, HTR5A, HTR6, HTR7 | 16.173 |
| [BP] GO:1901700 | response to oxygen-containing compound | ADRB2, AKR1B1, ALPL, APEX1, APP, AXL, BCL2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, ESR1, ESRRA, FABP3, GRIK5, GRM5, HMGCR, HSD11B2, HSD17B2, HTR1B, HTR5A, IGF1R, INSR, MMP2, MMP9, PIK3CA, POLB, PPARA, PRKCB, PRKCD, PRKCE, PTGS2, RORC, SRC, TEK, TRPV1, TYR | 15.6747 |
| [BP] GO:0010647 | positive regulation of cell communication | ADORA1, ADORA2A, ADRB1, ADRB2, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, F3, FLT3, GPR35, GRM1, HCAR2, HMGCR, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, INSR, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH | 15.658 |
| [BP] GO:0023056 | positive regulation of signaling | ADORA1, ADORA2A, ADRB1, ADRB2, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, F3, FLT3, GPR35, GRM1, HCAR2, HMGCR, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, INSR, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH | 15.6275 |
| [BP] GO:0010033 | response to organic substance | ADORA2A, ADRB2, AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSD11B2, HSD17B2, HSPA1A, HTR1B, HTR5A, IGF1R, INSR, KDR, MMP2, PIK3CA, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, RORC, SMAD3, SRC, TEK, TRPV1, TYR | 15.4426 |
| [BP] GO:0007210 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 14.8339 |
| [BP] GO:0098664 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 14.8339 |
| [BP] GO:0010646 | regulation of cell communication | ACHE, ADORA1, ADORA2A, ADRB1, ADRB2, AKR1B1, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F10, F3, FLT3, GPR35, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH | 14.3946 |
| [BP] GO:0009967 | positive regulation of signal transduction | ADORA1, ADORA2A, ADRB1, ADRB2, AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, F10, F3, FLT3, GPR35, GRM1, HMGCR, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, INSR, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH | 14.2778 |
| [BP] GO:0023051 | regulation of signaling | ACHE, ADORA1, ADORA2A, ADRB1, ADRB2, AKR1B1, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F10, F3, FLT3, GPR35, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH | 14.1703 |
| [BP] GO:0007188 | None | ADORA1, ADORA2A, ADRB1, ADRB2, CHRM1, CHRM2, CHRM4, CNR1, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 | 14.0407 |
| [BP] GO:0007193 | None | ADORA1, CHRM1, CHRM2, CHRM4, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 | 13.3343 |
| [BP] GO:1902533 | positive regulation of intracellular signal transduction | ADORA1, ADRB1, ADRB2, AKR1B1, ALOX15, APP, AXL, BCL2, CYP1B1, EGFR, F10, F3, FLT3, GPR35, GRM1, HMGCR, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, INSR, KDR, MET, MIF, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCE, PTGS2, PTPN1, SRC, TEK, XDH | 13.33 |
| [BP] GO:0048522 | positive regulation of cellular process | ACHE, ADORA1, ADORA2A, ADRB1, ADRB2, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CHRM1, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FLT3, GPR35, GRIK5, GRM1, GRM5, HCAR2, HMGCR, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH | 13.0114 |
| [BP] GO:0032879 | regulation of localization | ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, ADRB2, ALOX15, APEX1, APP, AXL, BCL2, CA2, CA7, CDK6, CHRM1, CNR1, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, F3, GPR35, GRIK5, GRM5, HCAR2, HMGCR, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, PIK3CB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TRPV1 | 12.125 |
| [BP] GO:0048584 | positive regulation of response to stimulus | ADORA1, ADORA2A, ADRB1, ADRB2, AKR1B1, ALOX15, APP, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESRRA, F10, F3, FABP4, FLT3, GPR35, GRM1, HMGCR, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, INSR, KDR, MET, MIF, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH | 12.1182 |
| [BP] GO:0048518 | positive regulation of biological process | ABCB1, ACHE, ADORA1, ADORA2A, ADRB1, ADRB2, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CHRM1, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GPR35, GRIK5, GRM1, GRM5, HCAR2, HMGCR, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SLC1A1, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH | 11.8357 |
| [BP] GO:0050896 | response to stimulus | ABCB1, ABCG2, ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, AKR1B1, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA9, CDK6, CHRM2, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, ESR1, ESRRA, F10, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HMGCR, HSD11B2, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TOP2A, TRPV1, TYR | 11.749 |
| [BP] GO:0042493 | response to drug | ABCB1, ABCG2, ADORA2A, AKR1B1, APEX1, AXL, BCL2, CA9, CDK6, CNR1, CNR2, CYP1A1, CYP1B1, EGFR, FABP3, HMGCR, HSD11B2, HTR1B, HTR2A, HTR2B, HTR2C, KDR, POLB, PRKCD, PRKCE, PRKCG, PTGS2, SRC, TRPV1 | 11.6232 |
| [BP] GO:0003018 | None | ADORA1, ADORA2A, ADRB1, ADRB2, CHRM1, EGFR, HMGCR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2, SRC, TEK | 11.5762 |
| [BP] GO:1902531 | regulation of intracellular signal transduction | ADORA1, ADRB1, ADRB2, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DUSP3, DYRK1A, EGFR, ESR1, F10, F3, FLT3, GPR35, GRM1, HMGCR, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MET, MIF, MMP9, NUAK1, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TEK, XDH | 11.5666 |
| [BP] GO:0007165 | signal transduction | ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, AKR1B1, APP, AXL, BCL2, CA1, CA2, CDK6, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, CYP1B1, DNMT1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MIF, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TRPV1 | 11.5013 |
| [BP] GO:0099536 | None | ADORA2A, CHRM1, CHRM2, CHRM4, CNR1, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, PRKCG, SLC1A1 | 11.4484 |
| [BP] GO:0099537 | None | ADORA2A, CHRM1, CHRM2, CHRM4, CNR1, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, PRKCG, SLC1A1 | 11.4484 |
| [BP] GO:0050804 | modulation of chemical synaptic transmission | ACHE, ADORA1, ADORA2A, ADRB2, APP, BACE1, CA2, CA7, CNR1, CNR2, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1B, HTR2A, PRKCE, PTGS2 | 11.4117 |
| [BP] GO:0099177 | regulation of trans-synaptic signaling | ACHE, ADORA1, ADORA2A, ADRB2, APP, BACE1, CA2, CA7, CNR1, CNR2, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1B, HTR2A, PRKCE, PTGS2 | 11.4117 |
| [BP] GO:0043067 | regulation of programmed cell death | ADORA1, ADORA2A, AKR1B1, APEX1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GLO1, GRIK5, HCAR2, HMGCR, HSPA1A, HTR2B, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, TRPV1, XDH | 11.3823 |
| [BP] GO:0042127 | regulation of cell proliferation | ADORA1, ADORA2A, ADORA3, AKR1B1, APP, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, CYP1B1, DNMT1, EGFR, ESR1, ESRRA, F3, FABP3, FLT3, HMGCR, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, NUAK1, PIM1, PRKCA, PTGS1, PTGS2, SMAD3, SRC, TEK, TERT, XDH | 11.0851 |
| [BP] GO:0010941 | regulation of cell death | ADORA1, ADORA2A, AKR1B1, APEX1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GLO1, GRIK5, HCAR2, HMGCR, HSPA1A, HTR2B, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, TRPV1, XDH | 11.0489 |
| [BP] GO:0019220 | regulation of phosphate metabolic process | ADORA1, ADORA2A, ADRB1, ADRB2, ALOX15, APP, BCL2, CDC25B, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 10.9276 |
| [BP] GO:0042981 | regulation of apoptotic process | ADORA1, ADORA2A, AKR1B1, APEX1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GLO1, GRIK5, HCAR2, HMGCR, HSPA1A, HTR2B, IGF1R, KDR, MIF, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, TRPV1, XDH | 10.8335 |
| [BP] GO:0051174 | regulation of phosphorus metabolic process | ADORA1, ADORA2A, ADRB1, ADRB2, ALOX15, APP, BCL2, CDC25B, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 10.8241 |
| [BP] GO:0006629 | lipid metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ESR1, FABP3, FABP4, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, MIF, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, TBXAS1, TRPV1 | 10.7997 |
| [BP] GO:0042592 | homeostatic process | ABCG2, ADORA1, ADRB1, ADRB2, AKR1B1, APEX1, APP, AXL, BCL2, CA12, CA2, CA7, CNR1, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, GRIK5, GRM1, GRM5, HTR2A, HTR2B, HTR2C, INSR, MET, PIK3CA, PIK3CB, POLA1, POLB, PRKCB, PRKCE, SMAD3, SRC, TERT, TRPV1 | 10.7578 |
| [BP] GO:0051049 | regulation of transport | ABCB1, ACHE, ADORA1, ADORA2A, ADRB2, ALOX15, APP, AXL, BCL2, CA2, CA7, CHRM1, CNR1, CYP19A1, EGFR, GPR35, GRIK5, GRM5, HCAR2, HMGCR, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, INSR, MIF, MMP12, MMP9, PIK3CB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SMAD3, SRC, TERT, TRPV1 | 10.6696 |
| [BP] GO:0032844 | regulation of homeostatic process | ADORA1, ADORA2A, AURKB, BCL2, CA2, CA7, CDK6, CNR1, EGFR, HCAR2, HMGCR, HTR2A, HTR2B, HTR2C, KDR, MIF, PIK3CB, PRKCE, PTGS2, SRC, TNKS, TNKS2, TRPV1 | 10.664 |
| [BP] GO:0007268 | None | ADORA2A, CHRM1, CHRM2, CHRM4, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, PRKCG, SLC1A1 | 10.664 |
| [BP] GO:0098916 | None | ADORA2A, CHRM1, CHRM2, CHRM4, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, PRKCG, SLC1A1 | 10.664 |
| [BP] GO:0097746 | None | ADORA1, ADORA2A, ADRB1, ADRB2, CHRM1, EGFR, HMGCR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 10.5641 |
| [BP] GO:0035296 | None | ADORA1, ADORA2A, ADRB1, ADRB2, CHRM1, EGFR, HMGCR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 10.5641 |
| [BP] GO:0010562 | positive regulation of phosphorus metabolic process | ADORA1, ADORA2A, ADRB1, ADRB2, ALOX15, APP, BCL2, CDC25B, EGFR, ESRRB, FABP3, FLT3, GRM1, GRM5, HMGCR, HTR2A, HTR2B, HTR2C, INSR, KDR, MIF, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 10.4502 |
| [BP] GO:0045937 | positive regulation of phosphate metabolic process | ADORA1, ADORA2A, ADRB1, ADRB2, ALOX15, APP, BCL2, CDC25B, EGFR, ESRRB, FABP3, FLT3, GRM1, GRM5, HMGCR, HTR2A, HTR2B, HTR2C, INSR, KDR, MIF, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 10.4502 |
| [BP] GO:0051966 | regulation of synaptic transmission, glutamatergic | ADORA1, ADORA2A, CNR1, EGFR, GRM1, GRM3, GRM5, GRM8, HTR1B, HTR2A, PTGS2 | 10.3583 |
| [BP] GO:0014070 | response to organic cyclic compound | ADORA2A, ALPL, APEX1, APP, BCL2, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FLT3, HSD11B2, HTR1B, HTR5A, PRKCE, PRKCG, PTGS2, RORC, SRC, TEK, TRPV1, TYR | 10.2386 |
| [BP] GO:0009719 | response to endogenous stimulus | ADRB2, AKR1B1, ALPL, APEX1, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DNMT1, EGFR, ESR1, ESRRA, FABP3, FLT3, GRM5, HSD11B2, HTR1B, HTR5A, IGF1R, INSR, MMP2, PPARA, PRKCD, PRKCE, PTGS2, SMAD3, SRC, TEK, TRPV1 | 10.2386 |
| [BP] GO:0050880 | None | ADORA1, ADORA2A, ADRB1, ADRB2, CHRM1, EGFR, HMGCR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 10.2274 |
| [BP] GO:0035150 | None | ADORA1, ADORA2A, ADRB1, ADRB2, CHRM1, EGFR, HMGCR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 10.1875 |
| [BP] GO:0007154 | None | ADORA1, ADORA2A, ADRB1, ADRB2, AXL, BCL2, CHRM1, CHRM2, CHRM4, CNR1, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, PRKCG, PTGS2, SLC1A1, TEK, TRPV1 | 10.0287 |
| [BP] GO:0007267 | None | ADORA1, ADORA2A, ADRB1, ADRB2, CHRM1, CHRM2, CHRM4, CNR1, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, PRKCG, SLC1A1, TEK | 9.99552 |
| [BP] GO:0003013 | None | ADORA1, ADORA2A, ADRB1, ADRB2, CHRM1, EGFR, HMGCR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2, SRC, TEK | 9.91655 |
| [BP] GO:0032501 | multicellular organismal process | ADORA1, ADORA2A, ADRB1, ADRB2, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AXL, BCL2, CHRM1, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRB, F10, F3, FABP4, GRM1, GRM5, GRM8, HMGCR, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR7, IGF1R, INSR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PPARA, PRKCD, PRKCG, PTGS2, RORC, SMAD3, SRC, TEK, TNKS2, TRPV1, TYR | 9.86268 |
| [BP] GO:0007186 | G-protein coupled receptor signaling pathway | ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, APP, CA2, CHRM1, CHRM2, CHRM4, CNR1, CNR2, ESR1, GPR35, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, INSR, PIK3CA, PIK3CB, SRC | 9.37846 |
| [BP] GO:0033559 | unsaturated fatty acid metabolic process | ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MIF, PTGS1, PTGS2, TBXAS1 | 9.33792 |
| [BP] GO:0051173 | positive regulation of nitrogen compound metabolic process | ADORA1, ADORA2A, ADRB1, ADRB2, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH | 9.27988 |
| [BP] GO:0043069 | negative regulation of programmed cell death | ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HMGCR, HSPA1A, HTR2B, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIM1, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT | 9.27648 |
| [BP] GO:0010817 | regulation of hormone levels | ACHE, ADORA1, ADORA2A, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2C, PRKCA, PRKCE, SLC22A1 | 9.24367 |
| [BP] GO:0060548 | negative regulation of cell death | ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HMGCR, HSPA1A, HTR2B, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIM1, PPARA, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT | 9.12012 |
| [BP] GO:0097756 | None | ADORA1, HMGCR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 9.11141 |
| [BP] GO:0048583 | regulation of response to stimulus | ABCB1, ADORA1, ADORA2A, ADRB1, ADRB2, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, F10, F3, FABP4, FLT3, GPR35, GRM1, HMGCR, HSPA1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH | 9.09291 |
| [BP] GO:0070887 | cellular response to chemical stimulus | ADRB2, AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, ESR1, FABP4, FLT3, GRIK5, GRM5, HSPA1A, HTR1B, IGF1R, INSR, KDR, MMP2, MMP9, PIK3CA, PRKCB, PRKCD, PRKCE, PTGS2, RORC, SMAD3, SRC, TERT, TRPV1 | 9.08131 |
| [BP] GO:0040012 | regulation of locomotion | ADORA1, ADORA2A, ADORA3, APEX1, APP, BCL2, CDK6, CHRM1, CHRM4, CYP19A1, CYP1B1, EGFR, F10, F3, HTR1D, IGF1R, INSR, KDR, MET, MIF, MMP9, PRKCA, PRKCE, PTGS2, SMAD3, SRC, TEK, TERT | 9.05285 |
| [BP] GO:0023052 | None | ADORA1, ADORA2A, ADRB1, ADRB2, CHRM1, CHRM2, CHRM4, CNR1, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, PRKCG, SLC1A1, TEK | 9.05119 |
| [BP] GO:0010243 | response to organonitrogen compound | ADORA2A, ADRB2, AKR1B1, APEX1, APP, CNR1, CNR2, DNMT1, EGFR, FABP3, FLT3, GRM5, HSD11B2, HTR1B, IGF1R, INSR, MMP2, PPARA, PRKCD, PRKCE, PRKCG, PTGS2, SRC, TEK, TRPV1, TYR | 9.05119 |
| [BP] GO:0006690 | icosanoid metabolic process | ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MIF, PTGS1, PTGS2, TBXAS1 | 9.03001 |
| [BP] GO:0033993 | response to lipid | ALPL, AXL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, HTR1B, HTR5A, PRKCE, PTGS2, RORC, SRC, TYR | 8.75788 |
| [BP] GO:0009725 | response to hormone | AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HTR1B, HTR5A, INSR, PPARA, PRKCD, PRKCE, PTGS2, SRC, TEK, TRPV1 | 8.75788 |
| [BP] GO:0042327 | positive regulation of phosphorylation | ADORA1, ADRB2, ALOX15, APP, BCL2, CDC25B, EGFR, ESRRB, FLT3, GRM1, GRM5, HMGCR, HTR2A, HTR2B, HTR2C, INSR, KDR, MIF, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TEK, XDH | 8.75348 |
| [BP] GO:0031325 | positive regulation of cellular metabolic process | ADORA1, ADORA2A, ADRB1, ADRB2, ALOX15, APP, AURKB, BCL2, CDC25B, DNMT1, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH | 8.72184 |
| [BP] GO:0043066 | negative regulation of apoptotic process | ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HMGCR, HSPA1A, HTR2B, IGF1R, KDR, MIF, MMP9, PIK3CA, PIM1, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT | 8.72184 |
| [BP] GO:0071310 | cellular response to organic substance | ADRB2, AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CDK6, CYP1A1, CYP1B1, DNMT1, EGFR, ESR1, FABP4, FLT3, GRIK5, GRM5, HTR1B, IGF1R, INSR, KDR, MMP2, PIK3CA, PRKCB, PRKCD, PRKCE, PTGS2, RORC, SMAD3, SRC, TRPV1 | 8.70522 |
| [BP] GO:0044281 | small molecule metabolic process | ABCG2, ADORA2A, AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FUT7, GBA2, GLO1, HMGCR, HSPA1A, HTR2B, HTR2C, MIF, PIK3CA, PIM1, PPARA, PTGS1, PTGS2, TBXAS1, TYR, XDH | 8.63551 |
| [BP] GO:0009628 | response to abiotic stimulus | ADORA1, ADRB1, ADRB2, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, EGFR, GRM1, HMGCR, HSD11B2, HSPA1A, HTR1B, HTR2A, HTR2B, MMP2, POLB, PPARA, PRKCB, PRKCE, PTGS2, SMAD3, SRC, TEK, TERT, TRPV1, TYR | 8.62776 |
| [BP] GO:0001934 | positive regulation of protein phosphorylation | ADORA1, ADRB2, ALOX15, APP, BCL2, CDC25B, EGFR, FLT3, GRM1, GRM5, HMGCR, HTR2A, HTR2B, HTR2C, INSR, KDR, MIF, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TEK, XDH | 8.4864 |
| [BP] GO:0008284 | positive regulation of cell proliferation | AKR1B1, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, EGFR, ESR1, F3, FLT3, HMGCR, HTR1A, HTR1B, HTR2A, HTR2B, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, PIM1, PRKCA, PTGS2, TEK, TERT | 8.40577 |
| [BP] GO:0043410 | positive regulation of MAPK cascade | ADORA1, ADRB2, ALOX15, APP, EGFR, FLT3, GRM1, HMGCR, HTR2A, HTR2B, HTR2C, INSR, KDR, MIF, PIK3CB, PRKCA, PRKCE, PTPN1, SRC, TEK, XDH | 8.40484 |
| [BP] GO:1901698 | response to nitrogen compound | ADORA2A, ADRB2, AKR1B1, APEX1, APP, CNR1, CNR2, DNMT1, EGFR, FABP3, FLT3, GRM5, HSD11B2, HTR1B, IGF1R, INSR, MMP2, PPARA, PRKCD, PRKCE, PRKCG, PTGS2, SRC, TEK, TRPV1, TYR | 8.36744 |
| [BP] GO:0032228 | regulation of synaptic transmission, GABAergic | ADORA1, ADORA2A, CA2, CA7, CNR1, CNR2, HTR1B, PRKCE | 8.28069 |
| [BP] GO:0006796 | phosphate-containing compound metabolic process | ACHE, ADORA2A, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DUSP3, DYRK1A, EGFR, FLT3, HMGCR, HSPA1A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, POLB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TEK, TNKS, XDH | 8.1858 |
| [BP] GO:0019748 | secondary metabolic process | AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR | 8.08102 |
| [BP] GO:0043408 | regulation of MAPK cascade | ADORA1, ADRB2, ALOX15, APP, DUSP3, EGFR, FLT3, GRM1, HMGCR, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MIF, PIK3CB, PRKCA, PRKCD, PRKCE, PTPN1, SRC, TEK, XDH | 8.04914 |
| [BP] GO:0009893 | positive regulation of metabolic process | ADORA1, ADORA2A, ADRB1, ADRB2, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH | 8.04179 |
| [BP] GO:0080134 | regulation of response to stress | ABCB1, ADORA1, ADORA2A, APP, CDK6, CNR1, CNR2, CYP19A1, DUSP3, DYRK1A, EGFR, ESR1, F3, FABP4, HMGCR, HSPA1A, IGF1R, MET, MIF, MMP12, MMP2, NUAK1, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 8.01809 |
| [BP] GO:0009966 | regulation of signal transduction | ADORA1, ADORA2A, ADRB1, ADRB2, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F10, F3, FLT3, GPR35, GRM1, HMGCR, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH | 7.99215 |
| [BP] GO:0048523 | negative regulation of cellular process | ACHE, ADORA1, ADORA2A, ADORA3, ADRB2, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPR35, GRM3, GRM8, HMGCR, HSPA1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH | 7.90473 |
| [BP] GO:0019369 | arachidonic acid metabolic process | ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2, TBXAS1 | 7.87269 |
| [BP] GO:0050790 | regulation of catalytic activity | ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, APP, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, GRM1, GRM3, GRM5, HMGCR, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, MIF, MMP9, NUAK1, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TNKS, XDH | 7.86027 |
| [BP] GO:0048878 | chemical homeostasis | ABCG2, AKR1B1, APP, BCL2, CA12, CA2, CA7, CNR1, EGFR, ESR1, FABP3, FABP4, GPR35, GRIK5, GRM1, GRM5, HTR2A, HTR2B, HTR2C, INSR, MET, PIK3CA, PIK3CB, PRKCB, PRKCE, SMAD3, TRPV1 | 7.8177 |
| [BP] GO:0008202 | steroid metabolic process | AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, ESR1, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 7.80617 |
| [BP] GO:0042325 | regulation of phosphorylation | ADORA1, ADORA2A, ADRB2, ALOX15, APP, BCL2, CDC25B, DUSP3, EGFR, ESRRB, FABP4, FLT3, GRM1, GRM5, HMGCR, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MIF, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TEK, XDH | 7.71772 |
| [BP] GO:0031399 | regulation of protein modification process | ADORA1, ADORA2A, ADRB2, ALOX15, APP, BCL2, CDC25B, DNMT1, DUSP3, DYRK1A, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TEK, XDH | 7.68114 |
| [BP] GO:0051716 | cellular response to stimulus | ADRB2, AKR1B1, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, ESR1, FABP4, FLT3, GRIK5, GRM1, GRM5, HSPA1A, HTR1B, IGF1R, INSR, KDR, MIF, MMP2, MMP9, NUAK1, PIK3CA, POLA1, POLB, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, TOP2A, TRPV1 | 7.66847 |
| [BP] GO:1901701 | cellular response to oxygen-containing compound | ADRB2, AKR1B1, APEX1, APP, AXL, CDK6, CYP1B1, DNMT1, EGFR, ESR1, GRIK5, GRM5, IGF1R, INSR, MMP2, MMP9, PIK3CA, PRKCB, PRKCD, PRKCE, PTGS2, RORC, SRC, TRPV1 | 7.66651 |
| [BP] GO:0006793 | phosphorus metabolic process | ACHE, ADORA2A, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DUSP3, DYRK1A, EGFR, FLT3, HMGCR, HSPA1A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, POLB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TEK, TNKS, XDH | 7.64052 |
| [BP] GO:0009636 | response to toxic substance | ADORA2A, AKR1B1, ALPL, APEX1, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1B1, HMGCR, HTR1B, HTR1D, KDR, POLB, PRKCD, PRKCE, SRC | 7.58457 |
| [BP] GO:0051239 | regulation of multicellular organismal process | ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, APP, AXL, BCL2, CA2, CDK6, CHRM1, CHRM2, CNR1, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, F3, GPR35, GRM1, HCAR2, HMGCR, HSPA1A, HTR2A, HTR2B, HTR2C, INSR, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, SLC1A1, SMAD3, SRC, TEK, TERT, TNKS2, TRPV1, XDH | 7.55355 |
| [BP] GO:0007166 | cell surface receptor signaling pathway | ADORA1, ADORA2A, ADORA3, ADRB2, APP, AXL, BCL2, CA1, CHRM4, CSNK2A1, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, MIF, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TRPV1 | 7.55355 |
| [BP] GO:0032270 | positive regulation of cellular protein metabolic process | ADORA1, ADRB2, ALOX15, APP, BCL2, CDC25B, DNMT1, DYRK1A, EGFR, ESR1, F3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, HTR2A, HTR2B, HTR2C, INSR, KDR, MIF, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 7.54222 |
| [BP] GO:0048519 | negative regulation of biological process | ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPR35, GRM3, GRM8, HCAR2, HMGCR, HSPA1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH | 7.54222 |
| [BP] GO:0051247 | positive regulation of protein metabolic process | ADORA1, ADRB2, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, EGFR, ESR1, F3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, HTR2A, HTR2B, HTR2C, INSR, KDR, MIF, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 7.53256 |
| [BP] GO:0031401 | positive regulation of protein modification process | ADORA1, ADRB2, ALOX15, APP, BCL2, CDC25B, DNMT1, DYRK1A, EGFR, FLT3, GRM1, GRM5, HMGCR, HTR2A, HTR2B, HTR2C, INSR, KDR, MIF, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TEK, XDH | 7.50357 |
| [BP] GO:0032845 | None | ADORA1, BCL2, HMGCR, HTR2A, HTR2B, HTR2C, MIF, PRKCE, SRC, TNKS, TNKS2, TRPV1 | 7.50357 |
| [BP] GO:0001932 | regulation of protein phosphorylation | ADORA1, ADORA2A, ADRB2, ALOX15, APP, BCL2, CDC25B, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MIF, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TEK, XDH | 7.4321 |
| [BP] GO:0019216 | regulation of lipid metabolic process | ADORA1, CNR1, CYP1A1, FABP3, FLT3, HCAR2, HMGCR, HTR2A, HTR2B, HTR2C, PPARA, PRKCD, PRKCE, PTGS2, RORC, SRC, TEK | 7.38523 |
| [BP] GO:0008152 | metabolic process | ABCG2, ACHE, ADORA1, ADORA2A, ADRB1, ADRB2, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CES2, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC22A2, SMAD3, SRC, TBXAS1, TEK, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH | 7.32678 |
| [BP] GO:0090066 | None | ADORA1, ADORA2A, ADRB1, ADRB2, ALOX15, CHRM1, EGFR, HMGCR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PRKCD, PRKCE, PTGS2 | 7.28207 |
| [BP] GO:1903727 | positive regulation of phospholipid metabolic process | FABP3, FLT3, HTR2A, HTR2B, HTR2C, PRKCD, SRC, TEK | 7.27797 |
| [BP] GO:0006468 | protein phosphorylation | APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DYRK1A, EGFR, FLT3, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK, TNKS | 7.24176 |
| [BP] GO:0065009 | regulation of molecular function | ABCB1, ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, APP, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, FLT3, GPR35, GRM1, GRM3, GRM5, HMGCR, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, MET, MIF, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TNKS, TRPV1, XDH | 7.23694 |
| [BP] GO:0007215 | None | APP, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 | 7.20866 |
| [BP] GO:1901568 | fatty acid derivative metabolic process | ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MIF, PTGS1, PTGS2, TBXAS1 | 7.16594 |
| [BP] GO:0065007 | biological regulation | ABCB1, ABCG2, ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CDK6, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GLO1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH | 7.14454 |
| [BP] GO:0045834 | positive regulation of lipid metabolic process | FABP3, FLT3, HTR2A, HTR2B, HTR2C, PPARA, PRKCD, PRKCE, PTGS2, SRC, TEK | 7.10284 |
| [BP] GO:0032502 | developmental process | ACHE, ADORA1, ADORA2A, ADRB1, ADRB2, AKR1B1, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA9, CDC25B, CDK6, CHRM1, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, DYRK1A, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD11B1, HSD17B2, HTR2A, HTR2B, HTR5A, INSR, KDR, MET, MIF, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, POLB, PPARA, PRKCA, PRKCD, PTGS2, RORC, SMAD3, SRC, TEK, TERT, TNKS2, TOP2A, TYR | 7.03257 |
| [BP] GO:2000145 | regulation of cell motility | ADORA1, ADORA3, APEX1, APP, BCL2, CDK6, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MIF, MMP9, PRKCA, PRKCE, PTGS2, SMAD3, SRC, TEK, TERT | 6.96658 |
| [BP] GO:0010604 | positive regulation of macromolecule metabolic process | ADORA1, ADRB2, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP2A, XDH | 6.95317 |
| [BP] GO:0051240 | positive regulation of multicellular organismal process | ADORA2A, ADRB1, ADRB2, APP, AXL, BCL2, CA2, CNR1, CYP1B1, EGFR, ESRRB, F3, HCAR2, HMGCR, HSPA1A, HTR2A, HTR2B, KDR, MET, MIF, MMP12, MMP9, PIM1, PRKCA, PRKCB, PRKCE, PTGS2, SLC1A1, SMAD3, SRC, TEK, TERT, TRPV1 | 6.94907 |
| [BP] GO:0003008 | None | ADORA1, ADORA2A, ADRB1, ADRB2, AKR1B1, APP, BCL2, CHRM1, CNR1, CNR2, CYP1B1, EGFR, GRM1, GRM5, GRM8, HMGCR, HSD11B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, INSR, PIK3CA, PRKCG, PTGS2, SRC, TEK, TRPV1, TYR | 6.78258 |
| [BP] GO:0030334 | regulation of cell migration | ADORA1, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MIF, MMP9, PRKCA, PRKCE, PTGS2, SMAD3, SRC, TEK, TERT | 6.77777 |
| [BP] GO:0010035 | response to inorganic substance | AKR1B1, ALOX15, APEX1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MMP9, PRKCD, PTGS2, SRC, TERT | 6.70104 |
| [BP] GO:0007198 | None | HTR1A, HTR1B, HTR5A, HTR7 | 6.60419 |
| [BP] GO:0009892 | negative regulation of metabolic process | ADORA1, ADORA2A, APEX1, APP, AURKB, BCL2, CNR1, CNR2, CSNK2A1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HCAR2, HMGCR, HSPA1A, HTR1B, HTR1E, HTR2B, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, TNKS, TNKS2, TRPV1, XDH | 6.55676 |
| [BP] GO:0007610 | None | ADORA2A, APP, BCL2, CNR1, EGFR, GRM1, GRM5, HMGCR, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, INSR, PPARA, PRKCE, PRKCG, PTGS2, TRPV1 | 6.45838 |
| [BP] GO:0043269 | regulation of ion transport | ABCB1, ADORA1, ADORA2A, ADRB2, APP, BCL2, CA2, CA7, CHRM1, CNR1, GPR35, GRM5, HTR1A, HTR1B, HTR2A, MIF, MMP9, PRKCD, PRKCE, PTGS2 | 6.38702 |
| [BP] GO:0044255 | cellular lipid metabolic process | ACHE, AKR1B10, ALOX15, ALOX5, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, FABP3, FABP4, FUT7, GBA2, HMGCR, MET, MIF, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, TBXAS1 | 6.32888 |
| [BP] GO:0070372 | regulation of ERK1 and ERK2 cascade | ALOX15, APP, DUSP3, EGFR, HMGCR, HTR2A, HTR2B, HTR2C, KDR, MIF, PRKCA, PTPN1, SRC, TEK | 6.31829 |
| [BP] GO:0051270 | regulation of cellular component movement | ADORA1, ADORA3, APEX1, APP, BCL2, CDK6, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MIF, MMP9, PRKCA, PRKCE, PTGS2, SMAD3, SRC, TEK, TERT | 6.29749 |
| [BP] GO:0044093 | positive regulation of molecular function | ABCB1, ADORA1, ADRB1, ADRB2, APP, AURKB, BCL2, CDC25B, EGFR, ESR1, ESR2, F3, FLT3, GRM1, GRM5, HSPA1A, HTR2A, HTR2B, INSR, MET, MIF, MMP9, PIK3CA, PIK3CB, PRKCB, PRKCD, PRKCE, PTPN1, SMAD3, SRC, TEK, TERT, TNKS, XDH | 6.17358 |
| [BP] GO:0030335 | positive regulation of cell migration | APP, BCL2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SMAD3, SRC, TEK, TERT | 6.17358 |
| [BP] GO:0009894 | regulation of catabolic process | ADORA1, ADRB2, APEX1, BCL2, CNR1, CSNK2A1, EGFR, ESRRB, HCAR2, HSPA1A, HTR2A, HTR2B, INSR, KDR, MET, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTPN1, SMAD3 | 6.11205 |
| [BP] GO:0048585 | negative regulation of response to stimulus | ADORA1, ADORA2A, ADRB2, ALOX15, BCL2, CDK6, CNR1, CNR2, CYP19A1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, HMGCR, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PRKCB, PRKCD, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 6.10491 |
| [BP] GO:0016310 | phosphorylation | APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DYRK1A, EGFR, FLT3, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK, TNKS | 6.07844 |
| [BP] GO:0046777 | protein autophosphorylation | AURKB, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, PRKCG, SRC, TEK | 6.07028 |
| [BP] GO:0043405 | regulation of MAP kinase activity | ADORA1, DUSP3, EGFR, FLT3, GRM1, HMGCR, HTR2A, HTR2B, IGF1R, INSR, MIF, PIK3CB, PRKCD, PTPN1, SRC | 6.05221 |
| [BP] GO:0070374 | positive regulation of ERK1 and ERK2 cascade | ALOX15, APP, EGFR, HMGCR, HTR2A, HTR2B, HTR2C, KDR, MIF, PRKCA, SRC, TEK | 6.05221 |
| [BP] GO:0043549 | regulation of kinase activity | ADORA1, ADORA2A, ADRB2, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, HTR2A, HTR2B, IGF1R, INSR, MIF, PIK3CA, PIK3CB, PRKCD, PTPN1, SRC, TEK | 6.05221 |
| [BP] GO:0070482 | response to oxygen levels | ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, POLB, PPARA, PRKCB, PRKCE, PTGS2, SMAD3, SRC, TEK, TERT | 6.018 |
| [BP] GO:0044092 | negative regulation of molecular function | ADORA2A, ADORA3, ADRB2, APP, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, DUSP3, ESR1, FABP4, GPR35, GRM3, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TNKS | 5.98541 |
| [BP] GO:2000147 | positive regulation of cell motility | APP, BCL2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SMAD3, SRC, TEK, TERT | 5.97724 |
| [BP] GO:0044057 | None | ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, CHRM1, CHRM2, EGFR, GPR35, GRM1, HCAR2, HTR2A, HTR2C, PRKCA, PTGS2, SLC1A1, SMAD3, TRPV1 | 5.9765 |
| [BP] GO:0044237 | cellular metabolic process | ABCG2, ACHE, ADORA2A, ADRB2, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CES2, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP2, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC22A2, SMAD3, SRC, TBXAS1, TEK, TERT, TNKS, TNKS2, TOP2A, TYR, XDH | 5.96761 |
| [BP] GO:0050795 | None | ADORA1, ADORA2A, CNR1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B | 5.96595 |
| [BP] GO:0006855 | None | ABCB1, ABCG2, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2 | 5.96595 |
| [BP] GO:0045859 | regulation of protein kinase activity | ADORA1, ADORA2A, ADRB2, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, HTR2A, HTR2B, IGF1R, INSR, MIF, PIK3CA, PIK3CB, PRKCD, PTPN1, SRC | 5.95497 |
| [BP] GO:0006631 | fatty acid metabolic process | ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, MIF, PPARA, PTGS1, PTGS2, TBXAS1 | 5.95064 |
| [BP] GO:0051338 | regulation of transferase activity | ADORA1, ADORA2A, ADRB2, APP, AURKB, CDC25B, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, HTR2A, HTR2B, IGF1R, INSR, MIF, PIK3CA, PIK3CB, PRKCD, PTPN1, SRC, TEK, TNKS | 5.94685 |
| [BP] GO:1901652 | response to peptide | ADRB2, AKR1B1, APEX1, APP, FABP3, GRM5, HSD11B2, IGF1R, INSR, PPARA, PRKCD, PTGS2, SRC, TEK, TRPV1 | 5.93808 |
| [BP] GO:0008283 | cell proliferation | ABCB1, ACHE, AURKB, BCL2, CHRM1, CHRM4, CYP1A1, EGFR, ESR1, FLT3, HTR1A, MET, MIF, PIK3CB, PIM1, POLA1, PRKCD, SRC, TEK, TYR | 5.92569 |
| [BP] GO:0019222 | regulation of metabolic process | ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, ALOX15, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSPA1A, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, POLA1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH | 5.89707 |
| [BP] GO:2000021 | regulation of ion homeostasis | ADORA1, ADORA2A, BCL2, CA2, CA7, HTR2A, HTR2B, HTR2C, KDR, PRKCE, SRC, TRPV1 | 5.83604 |
| [BP] GO:0051272 | positive regulation of cellular component movement | APP, BCL2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SMAD3, SRC, TEK, TERT | 5.83542 |
| [BP] GO:0001505 | regulation of neurotransmitter levels | ACHE, ADORA2A, CYP1B1, EGFR, GRIK5, HTR1A, INSR, PTGS2, SLC1A1, SLC22A2, SLC22A3, SMAD3, TRPV1 | 5.81505 |
| [BP] GO:0015701 | bicarbonate transport | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 5.80359 |
| [BP] GO:0010648 | negative regulation of cell communication | ACHE, ADORA1, ADRB2, BCL2, CNR2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, GPR35, HMGCR, HSPA1A, HTR1B, HTR2A, IGF1R, MET, MIF, MMP12, MMP9, PRKCB, PRKCD, PTGS2, PTPN1, SMAD3, SRC, TERT, XDH | 5.78393 |
| [BP] GO:0050801 | ion homeostasis | ABCG2, APP, BCL2, CA12, CA2, CA7, EGFR, ESR1, FABP3, GPR35, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CB, PRKCB, PRKCE, SMAD3, TRPV1 | 5.78393 |
| [BP] GO:0080090 | regulation of primary metabolic process | ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, ALOX15, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CNR1, CSNK2A1, CYP1A1, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSPA1A, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, POLA1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH | 5.78318 |
| [BP] GO:0023057 | negative regulation of signaling | ACHE, ADORA1, ADRB2, BCL2, CNR2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, GPR35, HMGCR, HSPA1A, HTR1B, HTR2A, IGF1R, MET, MIF, MMP12, MMP9, PRKCB, PRKCD, PTGS2, PTPN1, SMAD3, SRC, TERT, XDH | 5.75938 |
| [BP] GO:0051050 | positive regulation of transport | ABCB1, ACHE, ADORA1, ADORA2A, ADRB2, APP, AXL, BCL2, CA2, CHRM1, CYP19A1, EGFR, HCAR2, HTR2B, INSR, MIF, MMP12, PRKCD, PRKCE, PTGS2, SMAD3, SRC, TERT, TRPV1 | 5.75927 |
| [BP] GO:0001666 | response to hypoxia | ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PRKCB, PRKCE, PTGS2, SMAD3, SRC, TEK, TERT | 5.7522 |
| [BP] GO:0006950 | response to stress | ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, AKR1B1, ALOX15, APEX1, APP, AXL, BCL2, CA2, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, EGFR, HSD11B2, HSPA1A, HTR1A, HTR2C, MIF, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, POLA1, POLB, PPARA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, TRPV1 | 5.69601 |
| [BP] GO:0055114 | oxidation-reduction process | AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TBXAS1, TYR, XDH | 5.69136 |
| [BP] GO:0001676 | long-chain fatty acid metabolic process | ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2, TBXAS1 | 5.67869 |
| [BP] GO:0040017 | positive regulation of locomotion | APP, BCL2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SMAD3, SRC, TEK, TERT | 5.63998 |
| [BP] GO:1903725 | regulation of phospholipid metabolic process | FABP3, FLT3, HTR2A, HTR2B, HTR2C, PRKCD, SRC, TEK | 5.61039 |
| [BP] GO:0036293 | response to decreased oxygen levels | ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PRKCB, PRKCE, PTGS2, SMAD3, SRC, TEK, TERT | 5.61039 |
| [BP] GO:0031324 | negative regulation of cellular metabolic process | ADORA2A, APEX1, APP, AURKB, BCL2, CNR1, CSNK2A1, DNMT1, DUSP3, DYRK1A, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HMGCR, HSPA1A, HTR1B, HTR1E, HTR2B, IGF1R, MET, MIF, MMP12, MMP9, PIK3CA, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, TNKS, TNKS2, TRPV1, XDH | 5.53158 |
| [BP] GO:0042310 | None | HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7 | 5.50981 |
| [BP] GO:0043085 | positive regulation of catalytic activity | ADORA1, ADRB1, ADRB2, APP, AURKB, BCL2, CDC25B, EGFR, ESR1, F3, FLT3, GRM1, GRM5, HSPA1A, HTR2A, HTR2B, INSR, MIF, PIK3CA, PIK3CB, PRKCD, PRKCE, PTPN1, SMAD3, SRC, TEK, TERT, TNKS, XDH | 5.46044 |
| [BP] GO:0048661 | positive regulation of smooth muscle cell proliferation | AKR1B1, EGFR, HMGCR, HTR1B, MMP2, MMP9, PTGS2, TERT | 5.43511 |
| [BP] GO:0007568 | aging | APEX1, AURKB, BCL2, CNR1, CYP1A1, HMGCR, HTR2A, MIF, POLB, PRKCD, PTGS2, TERT | 5.3853 |
| [BP] GO:0018108 | peptidyl-tyrosine phosphorylation | AXL, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, MET, PRKCD, SRC, TEK | 5.3853 |
| [BP] GO:0032101 | regulation of response to external stimulus | ADORA1, ADORA2A, CNR1, CNR2, CYP19A1, EGFR, ESR1, F3, FABP4, HMGCR, KDR, MET, MIF, MMP12, PPARA, PRKCA, PRKCD, PRKCG, PTGS2, SMAD3, TEK | 5.3853 |
| [BP] GO:0098771 | inorganic ion homeostasis | ABCG2, APP, BCL2, CA12, CA2, CA7, EGFR, ESR1, GPR35, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CB, PRKCB, PRKCE, SMAD3, TRPV1 | 5.38224 |
| [BP] GO:0035556 | intracellular signal transduction | ADORA2A, ADRB1, ADRB2, AKR1B1, AXL, BCL2, CYP1B1, DNMT1, EGFR, GRM5, HTR2A, HTR2B, HTR5A, IGF1R, INSR, KDR, MET, MIF, NUAK1, PIK3CA, PIK3CB, POLB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC, TEK | 5.36732 |
| [BP] GO:0019725 | cellular homeostasis | ABCG2, APEX1, APP, BCL2, CA2, CA7, ESR1, GPR35, GRIK5, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB, POLA1, PRKCB, PRKCE, SMAD3, TRPV1 | 5.36301 |
| [BP] GO:0035690 | cellular response to drug | AKR1B1, APEX1, AXL, CDK6, CYP1B1, EGFR, HTR1B, KDR, PRKCD, PRKCE, PTGS2, SRC, TRPV1 | 5.35897 |
| [BP] GO:0030168 | platelet activation | AXL, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC | 5.35143 |
| [BP] GO:0009987 | cellular process | ABCB1, ABCG2, ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CES2, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC22A1, SLC22A2, SMAD3, SRC, TBXAS1, TEK, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH | 5.33462 |
| [BP] GO:0018212 | peptidyl-tyrosine modification | AXL, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, MET, PRKCD, SRC, TEK | 5.32967 |
| [BP] GO:0071417 | cellular response to organonitrogen compound | ADRB2, AKR1B1, APEX1, APP, DNMT1, EGFR, GRM5, HTR1B, IGF1R, INSR, MMP2, PRKCD, PTGS2, SRC, TRPV1 | 5.31569 |
| [BP] GO:0055082 | cellular chemical homeostasis | ABCG2, APP, BCL2, CA2, CA7, ESR1, GPR35, GRIK5, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB, PRKCB, PRKCE, SMAD3, TRPV1 | 5.29123 |
| [BP] GO:0031323 | regulation of cellular metabolic process | ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, ALOX15, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CNR1, CSNK2A1, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, POLA1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH | 5.25937 |
| [BP] GO:0042391 | None | ADORA1, ADORA2A, ADRB2, APP, BCL2, CNR1, CNR2, GPR35, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC, TRPV1 | 5.25541 |
| [BP] GO:0051897 | positive regulation of protein kinase B signaling | AXL, EGFR, F10, F3, INSR, MET, PIK3CA, PIK3CB, SRC, TEK | 5.22813 |
| [BP] GO:0044070 | regulation of anion transport | ABCB1, ADORA1, ADORA2A, CA2, CA7, GRM5, MIF, PRKCD | 5.21703 |
| [BP] GO:0051046 | None | ACHE, ADORA1, ADORA2A, CNR1, CYP19A1, EGFR, GRIK5, HCAR2, HMGCR, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, MIF, MMP12, PRKCA, PRKCE, SRC, TRPV1 | 5.20342 |
| [BP] GO:0090087 | None | ACHE, ADORA1, ADORA2A, APP, CA2, CHRM1, CNR1, EGFR, HCAR2, HMGCR, HTR2B, HTR2C, MIF, MMP12, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC | 5.15993 |
| [BP] GO:0051171 | regulation of nitrogen compound metabolic process | ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, ALOX15, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, POLA1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH | 5.15577 |
| [BP] GO:0032787 | None | ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GBA2, GLO1, MIF, PPARA, PTGS1, PTGS2, TBXAS1 | 5.03422 |
| [BP] GO:0050806 | positive regulation of synaptic transmission | ADORA1, ADORA2A, ADRB2, APP, CA2, CA7, EGFR, PRKCE, PTGS2 | 5.03341 |
| [BP] GO:0032268 | regulation of cellular protein metabolic process | ADORA1, ADORA2A, ADRB2, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, F3, FABP4, FLT3, GRM1, GRM5, HMGCR, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 5.03341 |
| [BP] GO:0007200 | None | CHRM1, CHRM2, CHRM4, ESR1, GRM5, HTR2A, HTR2B, HTR2C | 5.0321 |
| [BP] GO:0072507 | divalent inorganic cation homeostasis | APP, BCL2, EGFR, ESR1, GPR35, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CB, PRKCB, PRKCE, SMAD3, TRPV1 | 5.03172 |
| [BP] GO:0015711 | organic anion transport | ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC1A1, SLC22A1, SLC22A2, SLC22A3, TRPV1 | 5.03172 |
| [BP] GO:1903530 | regulation of secretion by cell | ACHE, ADORA1, ADORA2A, CNR1, CYP19A1, EGFR, GRIK5, HCAR2, HMGCR, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, MIF, MMP12, PRKCA, PRKCE, SRC | 5.02924 |
| [BP] GO:0071495 | cellular response to endogenous stimulus | ADRB2, AKR1B1, APEX1, APP, DNMT1, EGFR, ESR1, FLT3, GRM5, HTR1B, IGF1R, INSR, MMP2, PRKCD, PRKCE, PTGS2, SMAD3, SRC, TRPV1 | 5.0211 |
| [BP] GO:0051347 | positive regulation of transferase activity | ADORA1, ADRB2, AURKB, CDC25B, EGFR, FLT3, GRM1, GRM5, HTR2A, HTR2B, INSR, MIF, PIK3CA, PIK3CB, PRKCD, PTPN1, SRC, TEK, TNKS | 5.00314 |
| [BP] GO:0033674 | positive regulation of kinase activity | ADORA1, ADRB2, CDC25B, EGFR, FLT3, GRM1, GRM5, HTR2A, HTR2B, INSR, MIF, PIK3CA, PIK3CB, PRKCD, PTPN1, SRC, TEK | 5.00192 |
| [BP] GO:0006730 | one-carbon metabolic process | CA1, CA12, CA2, CA4, CA7, CA9 | 4.99353 |
| [BP] GO:0018105 | peptidyl-serine phosphorylation | AURKB, BCL2, DYRK1A, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TNKS | 4.92754 |
| [BP] GO:1901699 | cellular response to nitrogen compound | ADRB2, AKR1B1, APEX1, APP, DNMT1, EGFR, GRM5, HTR1B, IGF1R, INSR, MMP2, PRKCD, PTGS2, SRC, TRPV1 | 4.91605 |
| [BP] GO:0051896 | regulation of protein kinase B signaling | AXL, EGFR, F10, F3, INSR, MET, PIK3CA, PIK3CB, SRC, TEK, XDH | 4.90509 |
| [BP] GO:0055080 | cation homeostasis | ABCG2, APP, BCL2, CA2, CA7, EGFR, ESR1, GPR35, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CB, PRKCB, PRKCE, SMAD3, TRPV1 | 4.88082 |
| [BP] GO:0046883 | regulation of hormone secretion | ADORA1, ADORA2A, CNR1, CYP19A1, EGFR, HCAR2, HMGCR, HTR1A, HTR2A, HTR2C, PRKCA, PRKCE | 4.8539 |
| [BP] GO:0030003 | cellular cation homeostasis | ABCG2, APP, BCL2, CA2, CA7, ESR1, GPR35, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CB, PRKCB, PRKCE, SMAD3, TRPV1 | 4.81025 |
| [BP] GO:0071900 | regulation of protein serine/threonine kinase activity | ADORA1, ADRB2, DUSP3, EGFR, FLT3, GRM1, HMGCR, HTR2A, HTR2B, IGF1R, INSR, MIF, PIK3CB, PRKCD, PTPN1, SRC | 4.78384 |
| [BP] GO:0019373 | epoxygenase P450 pathway | CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 | 4.76646 |
| [BP] GO:0007196 | None | GRM1, GRM3, GRM5, GRM8 | 4.75778 |
| [BP] GO:0071073 | None | FABP3, HTR2A, HTR2B, HTR2C | 4.75778 |
| [BP] GO:0006874 | cellular calcium ion homeostasis | APP, BCL2, ESR1, GPR35, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CB, PRKCB, PRKCE, SMAD3, TRPV1 | 4.75778 |
| [BP] GO:0071704 | organic substance metabolic process | ABCG2, ACHE, ADORA1, ADORA2A, ADRB2, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CDK6, CES2, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TBXAS1, TEK, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH | 4.72079 |
| [BP] GO:0006873 | cellular ion homeostasis | ABCG2, APP, BCL2, CA2, CA7, ESR1, GPR35, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CB, PRKCB, PRKCE, SMAD3, TRPV1 | 4.67863 |
| [BP] GO:0045860 | positive regulation of protein kinase activity | ADORA1, ADRB2, CDC25B, EGFR, FLT3, GRM1, GRM5, HTR2A, HTR2B, INSR, MIF, PIK3CA, PIK3CB, PRKCD, PTPN1, SRC | 4.6735 |
| [BP] GO:0018193 | peptidyl-amino acid modification | AURKB, AXL, BCL2, CSNK2A1, DYRK1A, EGFR, F10, FLT3, IGF1R, INSR, KDR, MET, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK, TNKS, TOP2A | 4.65769 |
| [BP] GO:0001775 | cell activation | ADORA2A, ALOX5, APP, AXL, BCL2, EGFR, FLT3, FUT7, HSPA1A, MIF, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, RORC, SMAD3, SRC, TRPV1 | 4.64471 |
| [BP] GO:0032846 | positive regulation of homeostatic process | ADORA2A, AURKB, CA2, CA7, CNR1, EGFR, HCAR2, PIK3CB, PTGS2, TNKS, TNKS2 | 4.63567 |
| [BP] GO:0055074 | calcium ion homeostasis | APP, BCL2, ESR1, GPR35, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CB, PRKCB, PRKCE, SMAD3, TRPV1 | 4.60885 |
| [BP] GO:0050794 | regulation of cellular process | ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA7, CA9, CDC25B, CDK6, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GLO1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH | 4.59808 |
| [BP] GO:2001225 | regulation of chloride transport | ABCB1, CA2, CA7, GRM5 | 4.55852 |
| [BP] GO:0044238 | primary metabolic process | ACHE, ADORA1, ADORA2A, ADRB2, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CDK6, CES2, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TBXAS1, TEK, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH | 4.55741 |
| [BP] GO:0072503 | cellular divalent inorganic cation homeostasis | APP, BCL2, ESR1, GPR35, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CB, PRKCB, PRKCE, SMAD3, TRPV1 | 4.55297 |
| [BP] GO:0050730 | None | ADORA1, APP, EGFR, FLT3, GRM5, HTR2A, MIF, PRKCD, PRKCE, PTPN1, SRC | 4.55297 |
| [BP] GO:0018209 | peptidyl-serine modification | AURKB, BCL2, DYRK1A, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TNKS | 4.54103 |
| [BP] GO:0048511 | rhythmic process | AXL, BCL2, CSNK2A1, DYRK1A, EGFR, ESR1, HTR7, PPARA, PRKCG, RORC, SRC, TOP2A | 4.54049 |
| [BP] GO:0051172 | None | ADORA2A, APEX1, APP, AURKB, CSNK2A1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HMGCR, HSPA1A, HTR1B, HTR1E, IGF1R, MIF, MMP12, MMP9, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, TNKS, TNKS2, TRPV1, XDH | 4.54049 |
| [BP] GO:0043271 | negative regulation of ion transport | ADORA1, BCL2, CNR1, GPR35, HTR1B, HTR2A, MMP9, PRKCE, PTGS2 | 4.54049 |
| [BP] GO:0042445 | hormone metabolic process | ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 4.52523 |
| [BP] GO:1900542 | None | ADORA2A, ADRB1, ESRRB, GRM3, GRM8, HTR1B, HTR1E, HTR2A, INSR, PPARA, PRKCA | 4.50902 |
| [BP] GO:0006979 | response to oxidative stress | AKR1B1, APEX1, APP, AXL, BCL2, CYP1B1, EGFR, HSPA1A, MMP9, PRKCD, PTGS1, PTGS2, SRC | 4.50375 |
| [BP] GO:0050789 | regulation of biological process | ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA7, CA9, CDC25B, CDK6, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GLO1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH | 4.49774 |
| [BP] GO:0043065 | positive regulation of apoptotic process | ADORA2A, BCL2, CNR1, CYP1B1, F3, GRIK5, HCAR2, HMGCR, MMP9, PIK3CB, PRKCD, PTGS2, SMAD3, SRC, TOP2A, TRPV1, XDH | 4.43924 |
| [BP] GO:0006140 | None | ADORA2A, ADRB1, ESRRB, GRM3, GRM8, HTR1B, HTR1E, HTR2A, INSR, PPARA, PRKCA | 4.38917 |
| [BP] GO:0002682 | regulation of immune system process | ADORA1, ADORA2A, ALOX15, APP, AXL, BCL2, CA2, CDK6, CNR1, CNR2, CYP19A1, DUSP3, ESR1, ESRRA, HCAR2, HSPA1A, MIF, MMP12, MMP2, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTPN1, SMAD3, SRC | 4.38917 |
| [BP] GO:0034614 | cellular response to reactive oxygen species | AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, PRKCD, SRC | 4.38917 |
| [BP] GO:0043068 | positive regulation of programmed cell death | ADORA2A, BCL2, CNR1, CYP1B1, F3, GRIK5, HCAR2, HMGCR, MMP9, PIK3CB, PRKCD, PTGS2, SMAD3, SRC, TOP2A, TRPV1, XDH | 4.38583 |
| [BP] GO:0015893 | None | ABCB1, ABCG2, CA2, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2 | 4.37949 |
| [BP] GO:1901564 | organonitrogen compound metabolic process | ABCG2, ACHE, ADORA2A, ADRB2, AKR1B1, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, CYP1A1, CYP1A2, DUSP3, DYRK1A, EGFR, ESR1, F10, F3, FLT3, FUT7, GBA2, GLO1, HMGCR, HSPA1A, HTR1A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIM1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TYR, XDH | 4.37949 |
| [BP] GO:0055065 | metal ion homeostasis | ABCG2, APP, BCL2, EGFR, ESR1, GPR35, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CB, PRKCB, PRKCE, SMAD3, TRPV1 | 4.37941 |
| [BP] GO:0008217 | None | ADORA1, ADRB1, ADRB2, CNR1, HSD11B2, PPARA, PTGS1, PTGS2, SMAD3 | 4.35933 |
| [BP] GO:0009266 | None | ADORA1, ADRB1, ADRB2, HSPA1A, HTR1B, HTR2A, HTR2B, PTGS2, TRPV1 | 4.33625 |
| [BP] GO:0006875 | cellular metal ion homeostasis | ABCG2, APP, BCL2, ESR1, GPR35, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CB, PRKCB, PRKCE, SMAD3, TRPV1 | 4.30303 |
| [BP] GO:0008610 | lipid biosynthetic process | ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MIF, PIK3CA, PIK3CB, PTGS1, PTGS2 | 4.30289 |
| [BP] GO:0060078 | None | ADORA1, ADORA2A, GRIA2, GRIA4, GRIK5, GRM5, TRPV1 | 4.28942 |
| [BP] GO:0048513 | animal organ development | ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, INSR, KDR, PIK3CA, POLB, PPARA, SMAD3, SRC, TEK, TYR | 4.27694 |
| [BP] GO:0018107 | peptidyl-threonine phosphorylation | BCL2, CSNK2A1, DYRK1A, PRKCA, PRKCB, PRKCD, TNKS | 4.25646 |
| [BP] GO:0006805 | xenobiotic metabolic process | CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, NQO2, PTGS1, RORC | 4.23037 |
| [BP] GO:0050728 | negative regulation of inflammatory response | ADORA1, ADORA2A, CNR2, CYP19A1, PPARA, PRKCD, SMAD3, TEK | 4.2028 |
| [BP] GO:0031347 | regulation of defense response | ADORA1, ADORA2A, CNR1, CNR2, CYP19A1, EGFR, ESR1, FABP4, HSPA1A, MMP12, MMP2, PPARA, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK | 4.18204 |
| [BP] GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PTPN1, SRC, TEK | 4.16494 |
| [BP] GO:0043393 | regulation of protein binding | ADRB2, APP, AURKB, BCL2, MET, MMP9, PPARA, PRKCD, SRC, TERT | 4.15798 |
| [BP] GO:0045787 | positive regulation of cell cycle | APEX1, APP, AURKB, CDC25B, CYP1A1, DUSP3, EGFR, INSR, MIF, PRKCA, PRKCE, SRC, TERT | 4.15798 |
| [BP] GO:0032847 | regulation of cellular pH reduction | BCL2, CA2, CA7 | 4.13323 |
| [BP] GO:0048871 | multicellular organismal homeostasis | ADORA1, ADRB1, ADRB2, AKR1B1, HTR2A, MET, PIK3CA, TRPV1 | 4.12974 |
| [BP] GO:0050994 | None | ADORA1, CNR1, HCAR2, PPARA, PRKCD, PRKCE | 4.12231 |
| [BP] GO:0051246 | regulation of protein metabolic process | ADORA1, ADORA2A, ADRB2, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, F3, FABP4, FLT3, GRM1, GRM5, HMGCR, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 4.11879 |
| [BP] GO:0032230 | positive regulation of synaptic transmission, GABAergic | ADORA2A, CA2, CA7, PRKCE | 4.09785 |
| [BP] GO:0080135 | regulation of cellular response to stress | APP, CDK6, DUSP3, DYRK1A, EGFR, HMGCR, HSPA1A, IGF1R, MET, MIF, NUAK1, PRKCD, PRKCG, PTGS2, PTPN1, TERT, XDH | 4.08521 |
| [BP] GO:0009895 | negative regulation of catabolic process | ADORA1, BCL2, CNR1, EGFR, HCAR2, HTR2B, MET, PIK3CA, PPARA, PRKCG, SMAD3 | 4.06123 |
| [BP] GO:0043406 | positive regulation of MAP kinase activity | ADORA1, EGFR, FLT3, GRM1, HTR2A, HTR2B, INSR, MIF, PIK3CB, PTPN1, SRC | 4.04644 |
| [BP] GO:0018210 | peptidyl-threonine modification | BCL2, CSNK2A1, DYRK1A, PRKCA, PRKCB, PRKCD, TNKS | 4.0281 |
| [BP] GO:0051054 | positive regulation of DNA metabolic process | AURKB, DNMT1, EGFR, IGF1R, INSR, PRKCD, PRKCG, SRC, TNKS, TNKS2 | 4.02504 |
| [BP] GO:1904951 | positive regulation of establishment of protein localization | ACHE, ADORA2A, APP, BCL2, CHRM1, EGFR, HCAR2, HTR2B, MIF, MMP12, PRKCD, PRKCE, PTGS2, SMAD3, SRC | 4.01706 |
| [BP] GO:0007346 | regulation of mitotic cell cycle | APEX1, APP, AURKB, BCL2, CDC25B, CDK6, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, PRKCA, SMAD3, TERT, TNKS, TOP2A | 4.00527 |
| [BP] GO:1902532 | negative regulation of intracellular signal transduction | BCL2, DUSP3, DYRK1A, ESR1, HMGCR, HSPA1A, IGF1R, MET, MIF, MMP9, PRKCD, PTGS2, PTPN1, SRC, XDH | 4.00007 |
| [BP] GO:0010942 | positive regulation of cell death | ADORA2A, BCL2, CNR1, CYP1B1, F3, GRIK5, HCAR2, HMGCR, MMP9, PIK3CB, PRKCD, PTGS2, SMAD3, SRC, TOP2A, TRPV1, XDH | 3.99124 |
| [BP] GO:0009891 | positive regulation of biosynthetic process | ADORA2A, ADRB1, ADRB2, APP, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MMP12, PPARA, PRKCD, PTGS2, RORC, SMAD3, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1 | 3.98644 |
| [BP] GO:0001659 | None | ADORA1, ADRB1, ADRB2, HTR2A, TRPV1 | 3.97911 |
| [BP] GO:0014065 | phosphatidylinositol 3-kinase signaling | HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB | 3.97911 |
| [BP] GO:0002791 | None | ACHE, ADORA1, ADORA2A, CNR1, EGFR, HCAR2, HMGCR, HTR2B, HTR2C, MIF, MMP12, PRKCA, PRKCE, SRC | 3.97911 |
| [BP] GO:0007216 | None | GRM1, GRM3, GRM5, GRM8 | 3.97687 |
| [BP] GO:0050727 | regulation of inflammatory response | ADORA1, ADORA2A, CNR1, CNR2, CYP19A1, EGFR, ESR1, FABP4, PPARA, PRKCD, PTGS2, SMAD3, TEK | 3.97519 |
| [BP] GO:0010634 | positive regulation of epithelial cell migration | KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC, TEK | 3.97081 |
| [BP] GO:2000377 | regulation of reactive oxygen species metabolic process | BCL2, CYP1B1, EGFR, INSR, PRKCD, PTGS2, SMAD3, TRPV1, XDH | 3.95978 |
| [BP] GO:0050890 | None | ADORA1, APP, CHRM1, CNR1, EGFR, GRM5, HMGCR, HTR2A, INSR, PRKCG, PTGS2 | 3.94297 |
| [BP] GO:0030155 | regulation of cell adhesion | ADORA2A, ALOX15, BCL2, CDK6, CYP1B1, DUSP3, KDR, NUAK1, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, SMAD3, SRC, TEK | 3.93424 |
| [BP] GO:0070201 | None | ACHE, ADORA2A, APP, BCL2, CHRM1, CNR1, EGFR, HCAR2, HMGCR, HTR2B, MIF, MMP12, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC | 3.93244 |
| [BP] GO:0031348 | negative regulation of defense response | ADORA1, ADORA2A, CNR2, CYP19A1, MMP12, PPARA, PRKCD, SMAD3, TEK | 3.92235 |
| [BP] GO:0048660 | regulation of smooth muscle cell proliferation | AKR1B1, EGFR, HMGCR, HTR1B, MMP2, MMP9, PTGS2, TERT | 3.90051 |
| [BP] GO:2000379 | positive regulation of reactive oxygen species metabolic process | EGFR, INSR, PRKCD, PTGS2, SMAD3, TRPV1, XDH | 3.88733 |
| [BP] GO:0051130 | positive regulation of cellular component organization | ADRB2, ALOX15, APP, AURKB, AXL, BCL2, CNR1, DNMT1, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, PRKCD, PRKCE, SMAD3, SRC, TEK, TNKS, TNKS2 | 3.86907 |
| [BP] GO:0000302 | response to reactive oxygen species | AKR1B1, APEX1, AXL, BCL2, CYP1B1, EGFR, MMP9, PRKCD, SRC | 3.86475 |
| [BP] GO:0007197 | None | CHRM1, CHRM2, CHRM4 | 3.78631 |
| [BP] GO:0071502 | None | HTR1B, HTR2B, TRPV1 | 3.78631 |
| [BP] GO:0010513 | None | HTR2A, HTR2B, HTR2C | 3.78631 |
| [BP] GO:0051098 | regulation of binding | ADRB2, APP, AURKB, BCL2, MET, MMP9, PPARA, PRKCD, SMAD3, SRC, TERT, TNKS | 3.77899 |
| [BP] GO:0010638 | positive regulation of organelle organization | ADRB2, ALOX15, AURKB, BCL2, DNMT1, HSPA1A, INSR, KDR, MET, MMP9, PRKCE, SMAD3, SRC, TEK, TNKS, TNKS2 | 3.7658 |
| [BP] GO:0042446 | hormone biosynthetic process | AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.75737 |
| [BP] GO:0006820 | anion transport | ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC1A1, SLC22A1, SLC22A2, SLC22A3, TRPV1 | 3.7519 |
| [BP] GO:0071071 | None | FABP3, HTR2A, HTR2B, HTR2C | 3.74697 |
| [BP] GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway | BCL2, HSPA1A, MIF, MMP9, PTGS2, PTPN1, SRC | 3.74461 |
| [BP] GO:0008150 | biological_process | ABCB1, ABCG2, ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CDK6, CES2, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SMAD3, SRC, TBXAS1, TEK, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH | 3.71217 |
| [BP] GO:0051222 | positive regulation of protein transport | ACHE, ADORA2A, APP, CHRM1, EGFR, HCAR2, HTR2B, MIF, MMP12, PRKCD, PRKCE, PTGS2, SMAD3, SRC | 3.69683 |
| [BP] GO:0071902 | positive regulation of protein serine/threonine kinase activity | ADORA1, ADRB2, EGFR, FLT3, GRM1, HTR2A, HTR2B, INSR, MIF, PIK3CB, PTPN1, SRC | 3.69027 |
| [BP] GO:0071407 | cellular response to organic cyclic compound | ALPL, APEX1, APP, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, PTGS2, RORC, SRC, TRPV1 | 3.69027 |
| [BP] GO:0032880 | regulation of protein localization | ACHE, ADORA2A, APP, BCL2, CHRM1, CNR1, CSNK2A1, EGFR, HCAR2, HMGCR, HTR2B, MIF, MMP12, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TERT | 3.69027 |
| [BP] GO:0031328 | positive regulation of cellular biosynthetic process | ADORA2A, ADRB1, ADRB2, APP, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, HTR2C, IGF1R, INSR, MET, MMP12, PPARA, PRKCD, PTGS2, RORC, SMAD3, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1 | 3.68324 |
| [BP] GO:0051223 | None | ACHE, ADORA2A, APP, CHRM1, CNR1, EGFR, HCAR2, HMGCR, HTR2B, MIF, MMP12, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC | 3.66864 |
| [BP] GO:0031329 | regulation of cellular catabolic process | ADRB2, APEX1, BCL2, CNR1, ESRRB, HSPA1A, HTR2A, HTR2B, INSR, KDR, MET, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCG, PTPN1 | 3.66208 |
| [BP] GO:0006811 | None | ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, GRIA2, GRIA4, GRIK5, HTR2A, HTR2B, HTR2C, PPARA, PRKCB, PRKCE, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, TRPV1 | 3.65741 |
| [BP] GO:0050805 | negative regulation of synaptic transmission | ACHE, ADORA1, CNR2, HTR1B, HTR2A, PTGS2 | 3.6535 |
| [BP] GO:0046889 | None | FABP3, HTR2A, HTR2B, HTR2C, PRKCD, PTGS2 | 3.6535 |
| [BP] GO:0046456 | icosanoid biosynthetic process | ALOX15, ALOX5, MIF, PTGS1, PTGS2 | 3.62855 |
| [BP] GO:0010810 | regulation of cell-substrate adhesion | ALOX15, BCL2, CDK6, KDR, PIK3CB, PRKCE, SMAD3, SRC, TEK | 3.62014 |
| [BP] GO:0045931 | positive regulation of mitotic cell cycle | APEX1, APP, CDC25B, CYP1A1, DUSP3, INSR, PRKCA, TERT | 3.55444 |
| [BP] GO:0040014 | regulation of multicellular organism growth | ADRB1, ADRB2, APP, BCL2, PIK3CA, TNKS2 | 3.54076 |
| [BP] GO:0001952 | regulation of cell-matrix adhesion | BCL2, CDK6, KDR, PIK3CB, SMAD3, SRC, TEK | 3.53151 |
| [BP] GO:0007207 | None | CHRM1, CHRM2, CHRM4 | 3.5194 |
| [BP] GO:0032229 | None | ADORA1, CNR2, HTR1B | 3.5194 |
| [BP] GO:0034599 | cellular response to oxidative stress | AKR1B1, APEX1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, PRKCD, SRC | 3.5168 |
| [BP] GO:0045913 | None | ESRRB, HTR2A, INSR, PPARA, PRKCE, SRC | 3.5096 |
| [BP] GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | ADORA2A, ADRB1, ADRB2, APP, AURKB, DNMT1, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, HTR2A, IGF1R, INSR, MET, MMP12, PPARA, PRKCD, PRKCG, PTPN1, RORC, SMAD3, SRC, TERT, TNKS, TNKS2, TOP2A | 3.4986 |
| [BP] GO:0050793 | regulation of developmental process | ADRB1, ADRB2, APP, AXL, BCL2, CA2, CDK6, CNR1, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, F3, HMGCR, HTR2A, HTR2C, INSR, KDR, MIF, NUAK1, PIK3CA, PIM1, PPARA, PRKCA, PRKCB, PTGS2, RORC, SMAD3, SRC, TEK, TERT, TNKS2, TRPV1, XDH | 3.49638 |
| [BP] GO:0006954 | inflammatory response | ADORA1, ADORA2A, ADORA3, ALOX15, AXL, CNR2, MIF, PIK3CA, PIK3CB, POLB, PTGS1, PTGS2, TRPV1 | 3.48861 |
| [BP] GO:0048856 | anatomical structure development | ACHE, ADORA1, ADORA2A, AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CA2, CDK6, CHRM1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, DYRK1A, EGFR, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, HTR5A, INSR, KDR, MMP9, PIK3CA, PIM1, POLB, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TYR | 3.48068 |
| [BP] GO:0060079 | None | ADORA1, ADORA2A, GRIA2, GRIA4, GRIK5, TRPV1 | 3.47787 |
| [BP] GO:0044236 | multicellular organism metabolic process | ADRB1, ADRB2, MMP1, MMP12, MMP2, MMP9, TRPV1 | 3.46074 |
| [BP] GO:1904407 | positive regulation of nitric oxide metabolic process | EGFR, INSR, PTGS2, SMAD3, TRPV1 | 3.42318 |
| [BP] GO:0045429 | positive regulation of nitric oxide biosynthetic process | EGFR, INSR, PTGS2, SMAD3, TRPV1 | 3.42318 |
| [BP] GO:0042542 | response to hydrogen peroxide | AKR1B1, APEX1, AXL, BCL2, CYP1B1, PRKCD, SRC | 3.41385 |
| [BP] GO:0034754 | cellular hormone metabolic process | AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 | 3.41385 |
| [BP] GO:1900543 | None | GRM3, GRM8, HTR1B, HTR1E, PPARA, PRKCA | 3.41385 |
| [BP] GO:0002793 | None | ACHE, ADORA1, ADORA2A, EGFR, HCAR2, HTR2B, MIF, MMP12, PRKCE, SRC | 3.41244 |
| [BP] GO:0051726 | regulation of cell cycle | APEX1, APP, AURKB, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, MIF, PIM1, PRKCA, PRKCE, PTGS2, SMAD3, SRC, TERT, TNKS, TOP2A | 3.41242 |
| [BP] GO:0045980 | None | GRM3, GRM8, HTR1B, HTR1E, PPARA, PRKCA | 3.38156 |
| [BP] GO:0045776 | None | ADORA1, ADRB1, ADRB2, CNR1, PPARA | 3.37784 |
| [BP] GO:0045766 | positive regulation of angiogenesis | CYP1B1, F3, KDR, PRKCA, PRKCB, PTGS2, TEK, TERT | 3.36631 |
| [BP] GO:0051047 | None | ACHE, ADORA1, ADORA2A, CYP19A1, EGFR, HCAR2, HTR2B, MIF, MMP12, PRKCE, SRC, TRPV1 | 3.35614 |
| [BP] GO:0010038 | response to metal ion | ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2, TERT | 3.35122 |
| [BP] GO:0031960 | response to corticosteroid | ALPL, BCL2, EGFR, FLT3, HSD11B2, HTR1B, PTGS2, SRC | 3.34881 |
| [BP] GO:0007167 | enzyme linked receptor protein signaling pathway | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PTPN1, SMAD3, SRC, TEK | 3.3204 |
| [BP] GO:0009968 | negative regulation of signal transduction | ADRB2, BCL2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, HMGCR, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PRKCB, PRKCD, PTGS2, PTPN1, SMAD3, SRC, TERT, XDH | 3.31818 |
| [BP] GO:0009698 | phenylpropanoid metabolic process | CYP1A1, CYP2A13, CYP2A6 | 3.31134 |
| [BP] GO:0009804 | coumarin metabolic process | CYP1A1, CYP2A13, CYP2A6 | 3.31134 |
| [BP] GO:0010511 | None | HTR2A, HTR2B, HTR2C | 3.31134 |
| [BP] GO:1901653 | cellular response to peptide | ADRB2, AKR1B1, APEX1, APP, GRM5, IGF1R, INSR, PRKCD, SRC | 3.30511 |
| [BP] GO:0051701 | interaction with host | AXL, EGFR, HSPA1A, HTR2A, INSR, MET, SMAD3, SRC | 3.29809 |
| [BP] GO:0050999 | None | CNR1, CNR2, EGFR, HTR2B, TERT | 3.29182 |
| [BP] GO:0001503 | ossification | ALOX15, ALPL, BCL2, EGFR, MMP2, MMP9, TEK | 3.28034 |
| [BP] GO:0051209 | None | HTR2A, HTR2B, HTR2C, PRKCE, TRPV1 | 3.248 |
| [BP] GO:0051283 | None | HTR2A, HTR2B, HTR2C, PRKCE, TRPV1 | 3.248 |
| [BP] GO:0030814 | None | ADORA2A, ADRB1, GRM3, GRM8, HTR1B, HTR1E, PRKCA | 3.23578 |
| [BP] GO:1904707 | positive regulation of vascular smooth muscle cell proliferation | HTR1B, MMP2, MMP9, TERT | 3.22522 |
| [BP] GO:0050878 | regulation of body fluid levels | ADORA1, ADORA2A, AKR1B1, CHRM1, F10, F3, MET, PRKCA, PRKCD, PRKCE, SLC22A2, XDH | 3.17744 |
| [BP] GO:0019752 | carboxylic acid metabolic process | ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GBA2, GLO1, MIF, PIM1, PPARA, PTGS1, PTGS2, TBXAS1, TYR | 3.17082 |
| [BP] GO:0038083 | peptidyl-tyrosine autophosphorylation | EGFR, IGF1R, INSR, KDR, SRC | 3.15972 |
| [BP] GO:0060255 | regulation of macromolecule metabolic process | ACHE, ADORA1, ADORA2A, ADORA3, ADRB2, ALOX15, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A2, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GLO1, GRM1, GRM5, HMGCR, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, POLA1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH | 3.15514 |
| [BP] GO:0097237 | cellular response to toxic substance | AKR1B1, APEX1, AXL, CYP1B1, KDR, PRKCD, PRKCE | 3.14637 |
| [BP] GO:0048545 | response to steroid hormone | ALPL, BCL2, CA2, EGFR, FLT3, HSD11B2, HTR1B, PTGS2, SRC | 3.14209 |
| [BP] GO:0031649 | None | ADRB1, ADRB2, TRPV1 | 3.12733 |
| [BP] GO:0043434 | None | APEX1, FABP3, HSD11B2, INSR, PPARA, PRKCD, PTGS2, SRC, TEK, TRPV1 | 3.12109 |
| [BP] GO:0030815 | None | GRM3, GRM8, HTR1B, HTR1E, PRKCA | 3.12109 |
| [BP] GO:0006939 | None | HTR1D, HTR2A, HTR2B, HTR7, TRPV1 | 3.12109 |
| [BP] GO:0032102 | negative regulation of response to external stimulus | ADORA1, ADORA2A, CNR2, CYP19A1, HMGCR, MIF, PPARA, PRKCD, SMAD3, TEK | 3.11105 |
| [BP] GO:0032103 | positive regulation of response to external stimulus | CNR1, EGFR, F3, FABP4, KDR, MET, MIF, PRKCA, PTGS2, SMAD3 | 3.11105 |
| [BP] GO:0008210 | estrogen metabolic process | CYP19A1, CYP1B1, HSD17B1, HSD17B2 | 3.08317 |
| [BP] GO:0032098 | None | HTR2C, HTR4, PPARA, SLC22A3 | 3.08317 |
| [BP] GO:0061900 | None | ADORA2A, APP, EGFR, TRPV1 | 3.08317 |
| [BP] GO:0006082 | organic acid metabolic process | ABCG2, ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GBA2, GLO1, MIF, PIM1, PPARA, PTGS1, PTGS2, TBXAS1, TYR | 3.05286 |
| [BP] GO:1901615 | organic hydroxy compound metabolic process | AKR1B1, AKR1B10, ALOX15, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, GBA2, HMGCR, HTR1A, TYR | 3.0469 |
| [BP] GO:0030800 | None | GRM3, GRM8, HTR1B, HTR1E, PRKCA | 3.04183 |
| [BP] GO:0051480 | regulation of cytosolic calcium ion concentration | ESR1, GPR35, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PRKCE, SMAD3, TRPV1 | 3.0392 |
| [BP] GO:0006694 | steroid biosynthetic process | AKR1B1, CYP19A1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.0239 |
| [BP] GO:1904018 | positive regulation of vasculature development | CYP1B1, F3, KDR, PRKCA, PRKCB, PTGS2, TEK, TERT | 3.00804 |
| [BP] GO:0030522 | intracellular receptor signaling pathway | ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, RORC, SRC | 3.00804 |
| [BP] GO:0048143 | None | ADORA2A, APP, EGFR | 2.97532 |
| [BP] GO:0001973 | None | ADORA1, ADORA2A, ADORA3 | 2.97532 |
| [BP] GO:0002024 | None | ADRB1, ADRB2, TRPV1 | 2.97532 |
| [BP] GO:0050877 | None | ADORA1, ADORA2A, APP, CHRM1, CNR1, CNR2, CYP1B1, EGFR, GRM1, GRM5, GRM8, HMGCR, HTR2A, INSR, PRKCG, PTGS2, TRPV1, TYR | 2.9752 |
| [BP] GO:1903428 | positive regulation of reactive oxygen species biosynthetic process | EGFR, INSR, PTGS2, SMAD3, TRPV1 | 2.97084 |
| [BP] GO:0010676 | None | ESRRB, INSR, PPARA, PRKCE, SRC | 2.97084 |
| [BP] GO:0050708 | None | ACHE, ADORA2A, CNR1, EGFR, HCAR2, HMGCR, HTR2B, MIF, MMP12, PRKCA, PRKCE, SRC | 2.96001 |
| [BP] GO:0035235 | None | APP, GRIA2, GRIA4, GRIK5 | 2.96001 |
| [BP] GO:0006693 | None | CES2, MIF, PTGS1, PTGS2 | 2.96001 |
| [BP] GO:0006692 | None | CES2, MIF, PTGS1, PTGS2 | 2.96001 |
| [BP] GO:0051051 | negative regulation of transport | ADORA1, APP, BCL2, CNR1, GPR35, HMGCR, HSPA1A, HTR1B, HTR2A, MMP9, PRKCB, PRKCE, PTGS2 | 2.95939 |
| [BP] GO:1900182 | positive regulation of protein localization to nucleus | APP, EGFR, PRKCD, PTGS2, SMAD3, SRC, TERT | 2.95461 |
| [BP] GO:0043401 | steroid hormone mediated signaling pathway | ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC | 2.95461 |
| [BP] GO:0009611 | response to wounding | ACHE, ADORA3, ALOX15, BCL2, CYP1A1, EGFR, PPARA, SMAD3 | 2.95409 |
| [BP] GO:0051094 | positive regulation of developmental process | ADRB2, APP, AXL, BCL2, CA2, CNR1, CYP1B1, ESRRB, F3, HMGCR, HTR2A, HTR2C, INSR, KDR, PIM1, PRKCA, PRKCB, PTGS2, SMAD3, SRC, TEK, TERT | 2.94617 |
| [BP] GO:0050714 | None | ACHE, ADORA2A, EGFR, HCAR2, HTR2B, MIF, MMP12, PRKCE, SRC | 2.93731 |
| [BP] GO:0007611 | None | APP, CNR1, EGFR, GRM5, HMGCR, HTR2A, INSR, PRKCG, PTGS2 | 2.93731 |
| [BP] GO:0033555 | multicellular organismal response to stress | ADRB1, BCL2, HTR1A, HTR2C, PRKCG | 2.90525 |
| [BP] GO:0007271 | None | ADORA2A, CHRM1, CHRM2, CHRM4 | 2.90525 |
| [BP] GO:1904646 | cellular response to amyloid-beta | ADRB2, APP, GRM5, IGF1R | 2.90525 |
| [BP] GO:0009991 | response to extracellular stimulus | ALPL, AXL, BCL2, CNR1, CYP1A1, EGFR, HMGCR, HSD11B2, PTGS2, SRC, TRPV1, TYR | 2.89679 |
| [BP] GO:0043279 | None | ADORA2A, CNR1, HTR1B, PRKCE, PRKCG, TRPV1 | 2.87011 |
| [BP] GO:0032768 | None | CNR1, CNR2, EGFR, HTR2B, TERT | 2.87008 |
| [BP] GO:0032409 | None | ABCB1, ADRB2, APP, BCL2, GPR35, GRM5, MMP9, PRKCD, PRKCE | 2.84759 |
| [BP] GO:0097267 | omega-hydroxylase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 2.84759 |
| [BP] GO:0033032 | regulation of myeloid cell apoptotic process | BCL2, HCAR2, MIF, PIK3CB | 2.84759 |
| [BP] GO:0050873 | None | ADRB1, ADRB2, FABP4, PTGS2 | 2.84759 |
| [BP] GO:0016572 | histone phosphorylation | AURKB, PRKCA, PRKCB, PRKCD | 2.84759 |
| [BP] GO:0044267 | cellular protein metabolic process | ADORA2A, ADRB2, ALPL, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, DUSP3, DYRK1A, EGFR, ESR1, F10, FLT3, FUT7, HTR2B, IGF1R, INSR, KDR, MET, MMP1, MMP2, NUAK1, PIK3CA, PIM1, POLB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A | 2.81916 |
| [BP] GO:0016477 | cell migration | AXL, CNR2, CYP1B1, EGFR, FUT7, HTR2B, HTR6, KDR, MIF, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PRKCD, SRC, TEK | 2.81902 |
| [BP] GO:0097553 | None | HTR2A, HTR2B, HTR2C, PRKCE, TRPV1 | 2.80205 |
| [BP] GO:0045428 | regulation of nitric oxide biosynthetic process | EGFR, INSR, PTGS2, SMAD3, TRPV1 | 2.80205 |
| [BP] GO:0045936 | None | ADORA2A, DUSP3, FABP4, GRM3, GRM8, HMGCR, HTR1B, HTR1E, IGF1R, PPARA, PRKCA, PRKCD, PTPN1, XDH | 2.80198 |
| [BP] GO:0010563 | None | ADORA2A, DUSP3, FABP4, GRM3, GRM8, HMGCR, HTR1B, HTR1E, IGF1R, PPARA, PRKCA, PRKCD, PTPN1, XDH | 2.79489 |
| [BP] GO:0007205 | None | ADORA2A, CHRM1, HTR1B, HTR2B | 2.79317 |
| [BP] GO:0006636 | unsaturated fatty acid biosynthetic process | ALOX15, MIF, PTGS1, PTGS2 | 2.79317 |
| [BP] GO:0009896 | positive regulation of catabolic process | ADRB2, CSNK2A1, ESRRB, HSPA1A, HTR2A, INSR, KDR, PIK3CB, PPARA, PRKCD, PRKCE, PTPN1 | 2.78642 |
| [BP] GO:0007584 | response to nutrient | ALPL, CNR1, CYP1A1, EGFR, HMGCR, PTGS2, TRPV1, TYR | 2.74619 |
| [BP] GO:0034502 | protein localization to chromosome | AURKB, ESR1, TERT, TNKS, TNKS2 | 2.74568 |
| [BP] GO:1904645 | response to amyloid-beta | ADRB2, APP, GRM5, IGF1R | 2.74568 |
| [BP] GO:0030799 | None | ADORA2A, ADRB1, GRM3, GRM8, HTR1B, HTR1E, PRKCA | 2.74568 |
| [BP] GO:0007208 | None | HTR2A, HTR2C | 2.74568 |
| [BP] GO:0035408 | None | PRKCA, PRKCB | 2.74568 |
| [BP] GO:0009115 | None | AOX1, XDH | 2.74568 |
| [BP] GO:0006286 | base-excision repair, base-free sugar-phosphate removal | APEX1, POLB | 2.74568 |
| [BP] GO:0032147 | activation of protein kinase activity | ADORA1, ADRB2, EGFR, GRM1, INSR, PIK3CA, PIK3CB, PRKCD, PTPN1, SRC | 2.73922 |
| [BP] GO:2001233 | regulation of apoptotic signaling pathway | ADORA2A, BCL2, HSPA1A, MIF, MMP9, PRKCD, PTGS2, PTPN1, SMAD3, SRC, TERT | 2.73773 |
| [BP] GO:0019371 | None | PTGS1, PTGS2, TBXAS1 | 2.73724 |
| [BP] GO:0030817 | None | ADORA2A, ADRB1, GRM3, GRM8, HTR1B, PRKCA | 2.72045 |
| [BP] GO:0042752 | None | ADORA1, ADORA2A, PPARA, PRKCG, RORC, TOP2A | 2.72045 |
| [BP] GO:0033138 | positive regulation of peptidyl-serine phosphorylation | APP, BCL2, EGFR, MIF, PIK3CA, PTGS2 | 2.69727 |
| [BP] GO:0043436 | oxoacid metabolic process | ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GBA2, GLO1, MIF, PIM1, PPARA, PTGS1, PTGS2, TBXAS1, TYR | 2.68644 |
| [BP] GO:0070301 | cellular response to hydrogen peroxide | AKR1B1, APEX1, AXL, CYP1B1, PRKCD | 2.68644 |
| [BP] GO:0048015 | phosphatidylinositol-mediated signaling | HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB | 2.68644 |
| [BP] GO:0014074 | response to purine-containing compound | ADORA2A, APEX1, APP, PTGS2, TEK, TRPV1, TYR | 2.68048 |
| [BP] GO:0009410 | None | ADORA2A, CNR1, CNR2, EGFR, HTR1B, PRKCE, PRKCG | 2.68048 |
| [BP] GO:0051052 | regulation of DNA metabolic process | AURKB, DNMT1, EGFR, IGF1R, INSR, PIK3CA, PRKCD, PRKCG, SRC, TNKS, TNKS2 | 2.67709 |
| [BP] GO:0001101 | response to acid chemical | AKR1B1, DNMT1, EGFR, FABP3, HSD17B2, KDR, MMP2, PRKCE, PTGS2, SRC | 2.65986 |
| [BP] GO:0051828 | entry into other organism involved in symbiotic interaction | AXL, EGFR, HSPA1A, HTR2A, MET, SRC | 2.65738 |
| [BP] GO:0030260 | entry into host cell | AXL, EGFR, HSPA1A, HTR2A, MET, SRC | 2.65738 |
| [BP] GO:0051806 | entry into cell of other organism involved in symbiotic interaction | AXL, EGFR, HSPA1A, HTR2A, MET, SRC | 2.65738 |
| [BP] GO:0044409 | entry into host | AXL, EGFR, HSPA1A, HTR2A, MET, SRC | 2.65738 |
| [BP] GO:0045934 | None | APEX1, AURKB, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HSPA1A, HTR1B, HTR1E, MMP12, PPARA, PRKCA, RORC, SMAD3, SRC, TERT, TNKS, TNKS2, TRPV1 | 2.65122 |
| [BP] GO:0042596 | None | ADRB1, BCL2, HTR1A, HTR2C | 2.65122 |
| [BP] GO:0071248 | cellular response to metal ion | ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 | 2.65021 |
| [BP] GO:0015697 | None | SLC22A1, SLC22A2, SLC22A3 | 2.63305 |
| [BP] GO:0045759 | None | CNR1, CNR2, GPR35 | 2.63305 |
| [BP] GO:0015872 | None | SLC22A1, SLC22A2, SLC22A3 | 2.63305 |
| [BP] GO:0010907 | None | ESRRB, INSR, PPARA, SRC | 2.60289 |
| [BP] GO:0010863 | positive regulation of phospholipase C activity | EGFR, ESR1, HTR2A, HTR2B | 2.60289 |
| [BP] GO:0060402 | None | HTR2A, HTR2B, HTR2C, PRKCE, TRPV1 | 2.60075 |
| [BP] GO:0048017 | inositol lipid-mediated signaling | HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB | 2.60075 |
| [BP] GO:0050678 | None | CDK6, EGFR, F3, HTR2B, KDR, MMP12, PRKCA, SMAD3, TEK, XDH | 2.58419 |
| [BP] GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | ADORA2A, CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH | 2.58419 |
| [BP] GO:0006940 | None | ADORA1, ADRB2, CHRM1, CHRM2, PTGS2 | 2.57063 |
| [BP] GO:0010811 | positive regulation of cell-substrate adhesion | ALOX15, CDK6, KDR, PRKCE, SMAD3, TEK | 2.55261 |
| [BP] GO:0006703 | estrogen biosynthetic process | CYP19A1, HSD17B1, HSD17B2 | 2.53062 |
| [BP] GO:0001516 | None | MIF, PTGS1, PTGS2 | 2.53062 |
| [BP] GO:0046457 | None | MIF, PTGS1, PTGS2 | 2.53062 |
| [BP] GO:0031667 | response to nutrient levels | ALPL, BCL2, CNR1, CYP1A1, EGFR, HMGCR, HSD11B2, PTGS2, SRC, TRPV1, TYR | 2.53024 |
| [BP] GO:0002683 | negative regulation of immune system process | ADORA1, ADORA2A, ALOX15, AXL, CDK6, CNR1, CNR2, CYP19A1, DUSP3, MIF, MMP12 | 2.52149 |
| [BP] GO:0010564 | regulation of cell cycle process | APEX1, APP, AURKB, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, EGFR, HSPA1A, INSR, MIF, PRKCE, TERT, TNKS | 2.51985 |
| [BP] GO:2001234 | negative regulation of apoptotic signaling pathway | BCL2, HSPA1A, MIF, MMP9, PTGS2, PTPN1, SRC, TERT | 2.51985 |
| [BP] GO:0048869 | cellular developmental process | ACHE, ADORA2A, ADRB1, ADRB2, ALPL, APP, AXL, BCL2, CDC25B, CDK6, CYP1A1, EGFR, ESR1, ESRRB, FABP4, FLT3, FUT7, GBA2, GLO1, HMGCR, HTR2B, KDR, MET, MIF, MMP2, MMP9, PRKCD, PTGS2, RORC, SMAD3, SRC, TEK, TERT, TOP2A | 2.51874 |
| [BP] GO:1900076 | regulation of cellular response to insulin stimulus | ESRRA, PRKCB, PRKCD, PTPN1, SRC | 2.51659 |
| [BP] GO:0051234 | None | ABCB1, ABCG2, ACHE, ADORA1, ADORA2A, ADRB2, ALOX15, ALOX5, APP, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM1, EGFR, F10, FABP3, GRIA2, GRIA4, GRIK5, HSPA1A, HTR1B, HTR2A, HTR2B, HTR2C, MIF, MMP12, MMP9, PPARA, PRKCB, PRKCD, PRKCE, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SRC, TERT, TNKS, TRPV1, XDH | 2.50246 |
| [BP] GO:2001242 | regulation of intrinsic apoptotic signaling pathway | BCL2, HSPA1A, MIF, MMP9, PTGS2, PTPN1, SRC | 2.49125 |
| [BP] GO:0019538 | protein metabolic process | ACHE, ADORA2A, ADRB2, ALPL, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, DUSP3, DYRK1A, EGFR, ESR1, F10, F3, FLT3, FUT7, HTR2B, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIM1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A | 2.48616 |
| [BP] GO:0006464 | cellular protein modification process | ADRB2, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, DUSP3, DYRK1A, EGFR, ESR1, F10, FLT3, FUT7, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIM1, POLB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A | 2.48419 |
| [BP] GO:0036211 | protein modification process | ADRB2, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, DUSP3, DYRK1A, EGFR, ESR1, F10, FLT3, FUT7, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIM1, POLB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A | 2.48419 |
| [BP] GO:1900274 | regulation of phospholipase C activity | EGFR, ESR1, HTR2A, HTR2B | 2.47062 |
| [BP] GO:0010632 | regulation of epithelial cell migration | KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC, TEK | 2.47062 |
| [BP] GO:0042180 | None | AKR1B1, AKR1B10, CYP19A1, GLO1, HMGCR | 2.46216 |
| [BP] GO:0060065 | uterus development | CYP19A1, ESR1, SRC | 2.444 |
| [BP] GO:1990845 | None | ADRB1, ADRB2, TRPV1 | 2.444 |
| [BP] GO:0051967 | None | ADORA1, HTR1B, HTR2A | 2.444 |
| [BP] GO:1903524 | None | ADRB1, EGFR, HTR2A, PTGS2, SLC1A1 | 2.43675 |
| [BP] GO:0051128 | regulation of cellular component organization | ADRB2, ALOX15, APP, AURKB, AXL, BCL2, CNR1, CSNK2A1, DNMT1, EGFR, ESR1, ESR2, GRIK5, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, PIK3CB, PRKCD, PRKCE, PRKCG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A | 2.4348 |
| [BP] GO:0007190 | None | ADORA3, ADRB1, ADRB2, PRKCA | 2.43065 |
| [BP] GO:0015695 | None | SLC22A1, SLC22A2, SLC22A3, SLC47A1 | 2.38752 |
| [BP] GO:0048870 | cell motility | AXL, CNR2, CYP1B1, EGFR, FUT7, HTR2B, HTR6, KDR, MIF, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PRKCD, SRC, TEK | 2.38737 |
| [BP] GO:0048010 | vascular endothelial growth factor receptor signaling pathway | AXL, KDR, PIK3CA, PIK3CB, SRC | 2.38501 |
| [BP] GO:1903522 | None | ADORA1, ADORA3, ADRB1, CHRM1, CHRM2, EGFR, HTR2A, PTGS2, SLC1A1 | 2.37994 |
| [BP] GO:0050965 | None | ADORA1, HTR2A, TRPV1 | 2.36311 |
| [BP] GO:0050961 | None | ADORA1, HTR2A, TRPV1 | 2.36311 |
| [BP] GO:0051937 | None | SLC22A1, SLC22A2, SLC22A3 | 2.36311 |
| [BP] GO:0070198 | None | TERT, TNKS, TNKS2 | 2.36311 |
| [BP] GO:0046890 | None | FABP3, HMGCR, HTR2A, HTR2B, HTR2C, PRKCD, PTGS2 | 2.36311 |
| [BP] GO:0009755 | hormone-mediated signaling pathway | ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC | 2.36311 |
| [BP] GO:0038128 | None | EGFR, PIK3CA, PRKCA, SRC | 2.35222 |
| [BP] GO:1904705 | regulation of vascular smooth muscle cell proliferation | HTR1B, MMP2, MMP9, TERT | 2.35222 |
| [BP] GO:1903532 | None | ACHE, ADORA2A, CYP19A1, EGFR, HCAR2, HTR2B, MIF, MMP12, PRKCE, SRC | 2.34984 |
| [BP] GO:0099566 | None | GRM1, GRM5 | 2.34613 |
| [BP] GO:0098502 | DNA dephosphorylation | APEX1, POLB | 2.34613 |
| [BP] GO:0046110 | None | AOX1, XDH | 2.34613 |
| [BP] GO:0032849 | positive regulation of cellular pH reduction | CA2, CA7 | 2.34613 |
| [BP] GO:0002025 | None | ADRB1, ADRB2 | 2.34613 |
| [BP] GO:0040011 | locomotion | AXL, CNR2, CYP1B1, EGFR, FUT7, HTR2B, HTR6, KDR, MET, MIF, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PRKCD, SRC, TEK | 2.32929 |
| [BP] GO:0022898 | None | ABCB1, ADRB2, APP, BCL2, GPR35, GRM5, MMP9, PRKCE | 2.32834 |
| [BP] GO:0030802 | None | ADORA2A, ADRB1, GRM3, GRM8, HTR1B, PRKCA | 2.3231 |
| [BP] GO:0010605 | negative regulation of macromolecule metabolic process | ADORA2A, APEX1, APP, AURKB, CSNK2A1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, FABP4, HMGCR, HSPA1A, IGF1R, KDR, MIF, MMP12, MMP9, PPARA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, TNKS, TNKS2, TRPV1, XDH | 2.30542 |
| [BP] GO:0071241 | cellular response to inorganic substance | ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 | 2.3013 |
| [BP] GO:0051952 | None | ADORA1, ADORA2A, CNR1, HTR1B, HTR2A | 2.29975 |
| [BP] GO:0060401 | None | HTR2A, HTR2B, HTR2C, PRKCE, TRPV1 | 2.29975 |
| [BP] GO:0043412 | macromolecule modification | ADRB2, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, F10, FLT3, FUT7, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIM1, POLB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A | 2.29975 |
| [BP] GO:2000811 | negative regulation of anoikis | BCL2, PIK3CA, SRC | 2.29975 |
| [BP] GO:0032075 | None | HSPA1A, PRKCD, PTPN1 | 2.29975 |
| [BP] GO:0007213 | None | CHRM1, CHRM2, CHRM4 | 2.29975 |
| [BP] GO:0030540 | female genitalia development | AXL, CYP19A1, ESR1 | 2.29975 |
| [BP] GO:0070920 | None | EGFR, ESR1, TERT | 2.29975 |
| [BP] GO:0045986 | None | ADORA1, ADRB2, PTGS2 | 2.29975 |
| [BP] GO:0019372 | lipoxygenase pathway | ALOX15, ALOX5, PTGS2 | 2.29975 |
| [BP] GO:0051179 | None | ABCB1, ABCG2, ACHE, ADORA1, ADORA2A, ADRB2, ALOX15, ALOX5, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM1, EGFR, ESR1, F10, FABP3, GRIA2, GRIA4, GRIK5, HSPA1A, HTR1B, HTR2A, HTR2B, HTR2C, MIF, MMP12, MMP9, PPARA, PRKCB, PRKCD, PRKCE, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SRC, TERT, TNKS, TNKS2, TRPV1, XDH | 2.29931 |
| [BP] GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | ADORA1, FLT3, GRM5, HTR2A, MIF, PTPN1, SRC | 2.29398 |
| [BP] GO:0010675 | None | ESRRB, INSR, PPARA, PRKCE, RORC, SRC | 2.29373 |
| [BP] GO:0006952 | defense response | ADORA1, ADORA2A, ADORA3, ALOX15, APP, AXL, BCL2, CNR2, HTR1A, HTR2C, MIF, PIK3CA, PIK3CB, POLB, PRKCD, PTGS1, PTGS2, SRC, TRPV1 | 2.28669 |
| [BP] GO:0006109 | regulation of carbohydrate metabolic process | ESRRB, HTR2A, INSR, PPARA, PRKCE, RORC, SRC | 2.28122 |
| [BP] GO:0098657 | import into cell | ACHE, ADORA1, ADORA2A, ADRB2, ALOX15, APP, AXL, HTR1B, HTR2B, SLC1A1, SLC22A3, TRPV1 | 2.28014 |
| [BP] GO:0050679 | None | EGFR, F3, HTR2B, KDR, MMP12, PRKCA, TEK | 2.26719 |
| [BP] GO:1903793 | None | ABCB1, ADORA2A, MIF, PRKCD | 2.25437 |
| [BP] GO:0019932 | second-messenger-mediated signaling | ADORA2A, ADRB1, ADRB2, EGFR, GRM5, HTR2B, HTR5A, KDR | 2.25403 |
| [BP] GO:2000116 | regulation of cysteine-type endopeptidase activity | ADORA2A, CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH | 2.24209 |
| [BP] GO:0032355 | response to estradiol | CYP1A2, EGFR, ESR1, ESRRA, HTR5A, PTGS2 | 2.24161 |
| [BP] GO:0033554 | cellular response to stress | AKR1B1, ALOX15, APEX1, AXL, BCL2, CA2, CA9, CYP1B1, EGFR, HSPA1A, MIF, MMP9, NUAK1, POLA1, POLB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TERT, TOP2A, TRPV1 | 2.23081 |
| [BP] GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress | BCL2, CYP1B1, PRKCD | 2.22901 |
| [BP] GO:1904355 | positive regulation of telomere capping | AURKB, TNKS, TNKS2 | 2.22901 |
| [BP] GO:0006720 | isoprenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR, HMGCR | 2.22658 |
| [BP] GO:0006810 | None | ABCB1, ABCG2, ACHE, ADORA1, ADORA2A, ADRB2, ALOX15, ALOX5, APP, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM1, F10, FABP3, GRIA2, GRIA4, GRIK5, HSPA1A, HTR1B, HTR2A, HTR2B, HTR2C, MIF, MMP12, MMP9, PPARA, PRKCB, PRKCD, PRKCE, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SRC, TNKS, TRPV1, XDH | 2.21811 |
| [BP] GO:1901570 | None | ALOX15, ALOX5, MIF, PTGS1, PTGS2 | 2.21286 |
| [BP] GO:0030818 | None | GRM3, GRM8, HTR1B, PRKCA | 2.18499 |
| [BP] GO:0048732 | gland development | BCL2, CSNK2A1, CYP19A1, EGFR, INSR, PIK3CA, SMAD3, TYR | 2.1771 |
| [BP] GO:2000106 | regulation of leukocyte apoptotic process | AURKB, AXL, HCAR2, MIF, PIK3CB | 2.16769 |
| [BP] GO:0033273 | response to vitamin | ALPL, CYP1A1, EGFR, PTGS2, TYR | 2.16769 |
| [BP] GO:1903426 | None | EGFR, INSR, PTGS2, SMAD3, TRPV1 | 2.16769 |
| [BP] GO:0072488 | None | SLC22A1, SLC22A2, SLC22A3 | 2.16264 |
| [BP] GO:0016137 | None | AKR1B1, AKR1B10, GBA2 | 2.16264 |
| [BP] GO:0045821 | None | ESRRB, HTR2A, INSR | 2.16264 |
| [BP] GO:1900371 | None | ADORA2A, ADRB1, GRM3, GRM8, HTR1B, PRKCA | 2.16264 |
| [BP] GO:0009889 | regulation of biosynthetic process | ADORA2A, ADORA3, ADRB1, ADRB2, APEX1, APP, AURKB, BCL2, CA9, CSNK2A1, CYP1B1, DNMT1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, HTR1B, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MMP12, PIM1, POLA1, PPARA, PRKCA, PRKCB, PRKCD, PTGS2, RORC, SMAD3, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1 | 2.16042 |
| [BP] GO:0051248 | None | ADORA2A, APP, CSNK2A1, DNMT1, DUSP3, EGFR, FABP4, HMGCR, HSPA1A, IGF1R, MIF, MMP9, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SMAD3, SRC, XDH | 2.15595 |
| [BP] GO:0001954 | positive regulation of cell-matrix adhesion | CDK6, KDR, SMAD3, TEK | 2.15526 |
| [BP] GO:0046683 | response to organophosphorus | APEX1, APP, PTGS2, TEK, TRPV1, TYR | 2.14767 |
| [BP] GO:0030808 | None | ADORA2A, ADRB1, GRM3, GRM8, HTR1B, PRKCA | 2.14767 |
| [BP] GO:0019219 | regulation of nucleobase-containing compound metabolic process | ADORA2A, ADORA3, ADRB1, ADRB2, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1B1, DNMT1, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, GLO1, GRM3, GRM8, HSPA1A, HTR1B, HTR1E, HTR2A, IGF1R, INSR, MET, MMP12, PIK3CA, PIM1, POLA1, PPARA, PRKCA, PRKCB, PRKCD, PRKCG, PTPN1, RORC, SMAD3, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1 | 2.13289 |
| [BP] GO:0033135 | regulation of peptidyl-serine phosphorylation | APP, BCL2, EGFR, MIF, PIK3CA, PTGS2 | 2.13092 |
| [BP] GO:1901989 | None | APEX1, APP, CDC25B, CYP1A1, TERT | 2.12887 |
| [BP] GO:1901215 | negative regulation of neuron death | ADORA2A, AXL, BCL2, PIK3CA, PPARA, PRKCG, TERT | 2.12887 |
| [BP] GO:0090342 | None | CDK6, MIF, NUAK1, TERT | 2.12439 |
| [BP] GO:0030803 | None | GRM3, GRM8, HTR1B, PRKCA | 2.12439 |
| [BP] GO:0043086 | negative regulation of catalytic activity | ADORA2A, APP, CNR1, CNR2, CSNK2A1, DUSP3, FABP4, GRM3, HMGCR, IGF1R, MMP9, PRKCA, PRKCD, PTGS2, PTPN1, SRC | 2.12439 |
| [BP] GO:0007204 | positive regulation of cytosolic calcium ion concentration | ESR1, GPR35, GRM1, HTR2A, HTR2B, HTR2C, PRKCE, TRPV1 | 2.12051 |
| [BP] GO:0010595 | positive regulation of endothelial cell migration | KDR, MET, PRKCA, PTGS2, TEK | 2.10874 |
| [BP] GO:0001936 | None | F3, HTR2B, KDR, PRKCA, TEK, XDH | 2.10464 |
| [BP] GO:0016048 | None | ADORA1, HTR2A, TRPV1 | 2.10464 |
| [BP] GO:0051900 | regulation of mitochondrial depolarization | BCL2, KDR, SRC | 2.10464 |
| [BP] GO:0051197 | None | ESRRB, HTR2A, INSR | 2.10464 |
| [BP] GO:1901374 | None | SLC22A1, SLC22A2 | 2.10114 |
| [BP] GO:0033031 | positive regulation of neutrophil apoptotic process | HCAR2, PIK3CB | 2.10114 |
| [BP] GO:0070213 | None | TNKS, TNKS2 | 2.10114 |
| [BP] GO:0006145 | None | AOX1, XDH | 2.10114 |
| [BP] GO:0038171 | None | CNR1, CNR2 | 2.10114 |
| [BP] GO:0015874 | None | SLC22A1, SLC22A2 | 2.10114 |
| [BP] GO:0018894 | dibenzo-p-dioxin metabolic process | CYP1A1, CYP1A2 | 2.10114 |
| [BP] GO:0014827 | None | HTR1D, HTR2B | 2.10114 |
| [BP] GO:0050433 | None | ADORA2A, CNR1, HTR1B, HTR2A | 2.10114 |
| [BP] GO:0001938 | None | F3, HTR2B, KDR, PRKCA, TEK | 2.0969 |
| [BP] GO:0031331 | positive regulation of cellular catabolic process | ADRB2, ESRRB, HSPA1A, HTR2A, INSR, KDR, PIK3CB, PPARA, PRKCD, PTPN1 | 2.05475 |
| [BP] GO:0051341 | None | CNR1, CNR2, EGFR, HTR2B, TERT | 2.05279 |
| [BP] GO:0035588 | None | ADORA1, ADORA2A, ADORA3 | 2.04916 |
| [BP] GO:0035249 | None | ADORA2A, GRIA2, GRIK5 | 2.04916 |
| [BP] GO:0001525 | angiogenesis | CYP1B1, KDR, MMP2, PIK3CA, PIK3CB, PRKCA, PTGS2, TEK | 2.04563 |
| [BP] GO:0043523 | regulation of neuron apoptotic process | ADORA2A, AXL, BCL2, GRIK5, PIK3CA, PRKCG, TERT | 2.03996 |
| [BP] GO:1900372 | None | GRM3, GRM8, HTR1B, PRKCA | 2.03996 |
| [BP] GO:0030809 | None | GRM3, GRM8, HTR1B, PRKCA | 2.03996 |
| [BP] GO:0046626 | regulation of insulin receptor signaling pathway | PRKCB, PRKCD, PTPN1, SRC | 2.03996 |
| [BP] GO:0010518 | positive regulation of phospholipase activity | EGFR, ESR1, HTR2A, HTR2B | 2.03996 |
| [BP] GO:2001023 | None | ADORA2A, CNR1, HTR1B, HTR2A, MET | 2.03666 |
| [BP] GO:0043524 | negative regulation of neuron apoptotic process | ADORA2A, AXL, BCL2, PIK3CA, PRKCG, TERT | 2.03632 |
| [BP] GO:0050865 | regulation of cell activation | ADORA2A, APP, AXL, BCL2, CNR1, CNR2, DUSP3, MIF, PIK3CA, PRKCA, PRKCD, SRC | 2.02652 |
| [BP] GO:1903829 | positive regulation of cellular protein localization | APP, BCL2, CHRM1, EGFR, PRKCD, PRKCE, PTGS2, SMAD3, SRC, TERT | 2.02128 |
| [BP] GO:0051384 | response to glucocorticoid | ALPL, BCL2, EGFR, FLT3, HSD11B2, PTGS2 | 2.02128 |
| [BP] GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | ADORA2A, CSNK2A1, MMP9, PTGS2, SRC | 2.01772 |
| [BP] GO:0051588 | None | ADORA2A, GRIK5, HTR1A, HTR1B, HTR2C | 2.01772 |
| [BP] GO:0097755 | None | ADORA2A, ADRB1, ADRB2, EGFR | 2.01076 |
| [CC] GO:0005886 | plasma membrane | ABCB1, ABCG2, ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, ALOX15, ALPL, APP, AXL, BACE1, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, EGFR, ESR1, F10, F3, FLT3, GBA2, GLO1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SMAD3, SRC, TEK, TERT, TRPV1 | 15.3514 |
| [CC] GO:0031226 | intrinsic component of plasma membrane | ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, APP, AXL, BACE1, CA4, CHRM1, CHRM2, CHRM4, CNR1, CNR2, F10, F3, FLT3, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SLC1A1, SLC22A1, SLC22A2, SLC22A3, TEK, TRPV1 | 14.7417 |
| [CC] GO:0044459 | plasma membrane part | ABCB1, ABCG2, ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, ALOX15, APP, AXL, BACE1, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CNR1, CNR2, DUSP3, EGFR, F10, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PRKCG, PTGS2, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SRC, TEK, TRPV1 | 13.2101 |
| [CC] GO:0005887 | integral component of plasma membrane | ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, APP, AXL, BACE1, CHRM1, CHRM2, CHRM4, CNR1, CNR2, FLT3, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SLC1A1, SLC22A1, SLC22A2, SLC22A3, TEK, TRPV1 | 13.1594 |
| [CC] GO:0016020 | membrane | ABCB1, ABCG2, ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, ALOX15, ALOX5, ALPL, APP, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ESR1, F10, F3, FLT3, FUT7, GBA2, GLO1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SMAD3, SRC, TBXAS1, TEK, TERT, TNKS, TNKS2, TRPV1, TYR | 11.7314 |
| [CC] GO:0098590 | plasma membrane region | ABCB1, ABCG2, ADORA1, ADORA2A, ADRB2, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CNR1, EGFR, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR2A, INSR, MET, PRKCG, PTGS2, SLC1A1, SLC22A1, SRC, TEK, TRPV1 | 9.5476 |
| [CC] GO:0044425 | membrane part | ABCB1, ABCG2, ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, ALOX15, ALPL, APP, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ESR1, F10, F3, FLT3, FUT7, GBA2, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PIK3CA, PIK3CB, PRKCG, PTGS1, PTGS2, PTPN1, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SRC, TBXAS1, TEK, TRPV1, TYR | 9.38728 |
| [CC] GO:0043005 | None | ADORA1, ADORA2A, APP, BACE1, CA2, CHRM1, CHRM2, CNR1, CNR2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR2B, HTR5A, PRKCG, PTGS2, SRC | 5.31501 |
| [CC] GO:0031224 | None | ABCB1, ABCG2, ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, ALPL, APP, AXL, BACE1, CA12, CA14, CA4, CA9, CHRM1, CHRM2, CHRM4, CNR1, CNR2, EGFR, ESR1, F10, F3, FLT3, FUT7, GBA2, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, TBXAS1, TEK, TRPV1, TYR | 5.29746 |
| [CC] GO:0097060 | None | CHRM1, CHRM2, CHRM4, CNR1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, PRKCG, TRPV1 | 5.2905 |
| [CC] GO:0044456 | None | ACHE, ADORA1, ADORA2A, APP, CHRM1, CHRM2, CHRM4, CNR1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, PRKCG, SLC22A2, SRC, TRPV1 | 4.91605 |
| [CC] GO:0044464 | cell part | ABCB1, ABCG2, ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CDK6, CES2, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SMAD3, SRC, TBXAS1, TEK, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH | 4.77648 |
| [CC] GO:0120025 | None | ADORA1, ADORA2A, AKR1B1, APP, BACE1, CA2, CDK6, CHRM1, CHRM2, CNR1, CNR2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR2B, HTR5A, HTR6, PIK3CA, PRKCG, PTGS2, SRC, TEK | 4.58596 |
| [CC] GO:0016021 | None | ABCB1, ABCG2, ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, ALPL, APP, AXL, BACE1, CA12, CA14, CA9, CHRM1, CHRM2, CHRM4, CNR1, CNR2, EGFR, ESR1, F3, FLT3, FUT7, GBA2, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, TBXAS1, TEK, TRPV1, TYR | 4.52404 |
| [CC] GO:0042995 | cell projection | ADORA1, ADORA2A, AKR1B1, APP, BACE1, CA2, CDK6, CHRM1, CHRM2, CNR1, CNR2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR2B, HTR5A, HTR6, PIK3CA, PRKCG, PTGS2, SRC, TEK | 4.17493 |
| [CC] GO:0097458 | None | ADORA1, ADORA2A, APP, BACE1, CA2, CHRM1, CHRM2, CNR1, CNR2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR2A, HTR2B, HTR5A, INSR, PRKCG, PTGS1, PTGS2, SLC22A2, SRC, TRPV1 | 4.09928 |
| [CC] GO:0042734 | None | CNR1, GRIK5, GRM1, GRM3, GRM5, GRM8 | 3.72018 |
| [CC] GO:0005783 | None | ADORA1, APEX1, APP, BCL2, CA4, CES2, CYP19A1, FLT3, GBA2, GRIK5, HMGCR, HSPA1A, HTR5A, KDR, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, XDH | 3.69683 |
| [CC] GO:0014069 | None | ADORA1, ADORA2A, CHRM1, GRIK5, GRM1, GRM3, GRM5, PRKCG, SRC | 3.45469 |
| [CC] GO:0099572 | None | ADORA1, ADORA2A, CHRM1, GRIK5, GRM1, GRM3, GRM5, PRKCG, SRC | 3.45469 |
| [CC] GO:0043235 | receptor complex | ABCG2, ADRB2, APP, EGFR, GRIA2, GRIA4, GRIK5, GRM1, IGF1R, INSR, SMAD3 | 3.31818 |
| [CC] GO:0044432 | endoplasmic reticulum part | APP, BACE1, BCL2, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, F10, FLT3, GBA2, GRIA2, HMGCR, HSD11B1, HSD11B2, HSD17B2, PTGS1, PTGS2, PTPN1, TBXAS1 | 3.25419 |
| [CC] GO:0045121 | membrane raft | APP, BACE1, CNR1, EGFR, HTR2A, INSR, KDR, PTGS2, SRC, TEK | 2.95461 |
| [CC] GO:0098857 | membrane microdomain | APP, BACE1, CNR1, EGFR, HTR2A, INSR, KDR, PTGS2, SRC, TEK | 2.93599 |
| [CC] GO:0045211 | None | CHRM1, CHRM2, CHRM4, GRIA2, GRIA4, GRIK5, GRM3, TRPV1 | 2.51985 |
| [CC] GO:0048471 | perinuclear region of cytoplasm | ACHE, AKR1B1, APEX1, APP, CA4, EGFR, HSPA1A, PRKCA, PRKCD, PRKCE, PRKCG, SRC, TNKS2, TYR | 2.45775 |
| [CC] GO:0005789 | endoplasmic reticulum membrane | BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, GBA2, GRIA2, HMGCR, HSD11B1, HSD11B2, HSD17B2, PTGS1, PTGS2, TBXAS1 | 2.38315 |
| [CC] GO:0098589 | membrane region | APP, BACE1, CNR1, EGFR, HTR2A, INSR, KDR, PTGS2, SRC, TEK | 2.3633 |
| [CC] GO:0099056 | None | ADORA1, ADORA2A | 2.34613 |
| [CC] GO:0098889 | None | ADORA1, ADORA2A | 2.34613 |
| [CC] GO:0032589 | None | ADORA1, ADORA2A, INSR, TRPV1 | 2.29224 |
| [CC] GO:0044463 | None | ADORA1, ADORA2A, AKR1B1, APP, CA4, CA9, CHRM1, CHRM2, CNR1, GRIA2, GRIA4, GRIK5, GRM3, HTR2A, INSR, PTGS1, SRC, TRPV1 | 2.18873 |
| [CC] GO:0120038 | None | ADORA1, ADORA2A, AKR1B1, APP, CA4, CA9, CHRM1, CHRM2, CNR1, GRIA2, GRIA4, GRIK5, GRM3, HTR2A, INSR, PTGS1, SRC, TRPV1 | 2.18873 |
| [CC] GO:0016323 | basolateral plasma membrane | ADORA1, CA2, CA4, CA9, EGFR, SLC22A1, TEK | 2.12887 |
| [CC] GO:0031233 | None | CA4, F10, F3 | 2.04916 |
| [CC] GO:0045202 | None | ACHE, APP, CHRM1, CHRM2, CHRM4, EGFR, GRIA2, HTR2B | 2.00894 |
| [MF] GO:0008227 | None | ADRB1, ADRB2, CHRM1, CHRM2, CHRM4, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 17.6363 |
| [MF] GO:0030594 | None | CHRM1, CHRM2, CHRM4, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 17.5171 |
| [MF] GO:0099528 | None | CHRM1, CHRM2, CHRM4, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 17.2062 |
| [MF] GO:0038023 | signaling receptor activity | ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, AXL, CHRM1, CHRM2, CHRM4, CNR1, CNR2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, RORC, TEK, TRPV1 | 16.9969 |
| [MF] GO:0060089 | molecular transducer activity | ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, AXL, CDK6, CHRM1, CHRM2, CHRM4, CNR1, CNR2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, RORC, TEK, TRPV1 | 15.4426 |
| [MF] GO:0004872 | receptor activity | ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, AXL, CHRM1, CHRM2, CHRM4, CNR1, CNR2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, RORC, TEK, TRPV1 | 15.2635 |
| [MF] GO:0046914 | transition metal ion binding | ALOX15, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, PPARA, PRKCA, PRKCB, PRKCG, PTPN1, RORC, SMAD3, TBXAS1, TNKS, TYR, XDH | 15.2635 |
| [MF] GO:0004871 | signal transducer activity | ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, AXL, CHRM1, CHRM2, CHRM4, CNR1, CNR2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, PRKCE, RORC, SMAD3, TEK, TRPV1 | 15.2144 |
| [MF] GO:0043176 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 | 14.9459 |
| [MF] GO:0051378 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 | 14.9459 |
| [MF] GO:0004993 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 14.8339 |
| [MF] GO:0099589 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 14.8339 |
| [MF] GO:0043167 | ion binding | ABCB1, ABCG2, ACHE, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GLO1, HMGCR, HSD17B1, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SMAD3, SRC, TBXAS1, TEK, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH | 14.345 |
| [MF] GO:0099600 | transmembrane receptor activity | ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, AXL, CHRM1, CHRM2, CHRM4, CNR1, CNR2, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, TEK, TRPV1 | 14.0407 |
| [MF] GO:0004888 | transmembrane signaling receptor activity | ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, AXL, CHRM1, CHRM2, CHRM4, CNR1, CNR2, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, TEK, TRPV1 | 14.0407 |
| [MF] GO:0003824 | catalytic activity | ABCB1, ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BACE1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CDK6, CES2, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DUSP3, DYRK1A, EGFR, F10, F3, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, SRC, TBXAS1, TEK, TERT, TNKS, TNKS2, TOP2A, TYR, XDH | 11.1635 |
| [MF] GO:0008144 | drug binding | ABCB1, ABCG2, ACHE, AURKB, AXL, CDK6, CHRM1, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, DYRK1A, EGFR, FLT3, HSPA1A, HTR1B, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK, TOP2A, TRPV1 | 11.0227 |
| [MF] GO:0043169 | cation binding | ACHE, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, ESR1, ESR2, ESRRA, ESRRB, F10, GLO1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIM1, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SMAD3, TBXAS1, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH | 10.4564 |
| [MF] GO:0042165 | neurotransmitter binding | ACHE, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 | 9.43369 |
| [MF] GO:0004089 | carbonate dehydratase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 9.14925 |
| [MF] GO:0004930 | None | ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, CHRM1, CHRM2, CHRM4, CNR1, CNR2, GPR35, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 8.55509 |
| [MF] GO:0070405 | ammonium ion binding | ACHE, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 | 8.0432 |
| [MF] GO:0008270 | zinc ion binding | CA1, CA12, CA2, CA4, CA7, CA9, DNMT1, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, PPARA, PRKCA, PRKCB, PRKCG, PTPN1, RORC, SMAD3, TNKS | 7.76004 |
| [MF] GO:0008066 | None | GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 | 7.25136 |
| [MF] GO:0016491 | oxidoreductase activity | AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TBXAS1, TYR, XDH | 7.23694 |
| [MF] GO:0016835 | carbon-oxygen lyase activity | APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, POLB | 6.6728 |
| [MF] GO:0004672 | protein kinase activity | AURKB, AXL, CDK6, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK | 6.61714 |
| [MF] GO:0043560 | insulin receptor substrate binding | IGF1R, INSR, PIK3CA, PIK3CB, PRKCD | 6.17358 |
| [MF] GO:0004714 | transmembrane receptor protein tyrosine kinase activity | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK | 6.05221 |
| [MF] GO:0016773 | phosphotransferase activity, alcohol group as acceptor | AURKB, AXL, CDK6, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK | 5.98541 |
| [MF] GO:0005506 | iron ion binding | ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1, XDH | 5.9765 |
| [MF] GO:0016772 | transferase activity, transferring phosphorus-containing groups | AURKB, AXL, CDK6, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK, TERT | 5.96761 |
| [MF] GO:0046872 | metal ion binding | ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, ESR1, ESR2, ESRRA, ESRRB, F10, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIM1, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SMAD3, TBXAS1, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH | 5.92106 |
| [MF] GO:0020037 | heme binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2, SRC, TBXAS1 | 5.84845 |
| [MF] GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 | 5.78393 |
| [MF] GO:0048037 | cofactor binding | AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HMGCR, HSD11B2, HSD17B1, NQO2, POLA1, PTGS1, PTGS2, SRC, TBXAS1, XDH | 5.69694 |
| [MF] GO:0046906 | tetrapyrrole binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2, SRC, TBXAS1 | 5.57531 |
| [MF] GO:0004713 | protein tyrosine kinase activity | AXL, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, MET, PRKCD, SRC, TEK | 5.49524 |
| [MF] GO:0016301 | kinase activity | AURKB, AXL, CDK6, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK | 5.38532 |
| [MF] GO:0004697 | None | PRKCA, PRKCB, PRKCD, PRKCE, PRKCG | 5.3441 |
| [MF] GO:0019199 | transmembrane receptor protein kinase activity | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK | 5.32674 |
| [MF] GO:0097159 | organic cyclic compound binding | ABCB1, ABCG2, ADORA1, ADRB1, ADRB2, AOX1, APEX1, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HMGCR, HSD11B2, HSD17B1, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IGF1R, INSR, KDR, MET, MMP12, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TBXAS1, TEK, TERT, TOP2A, TRPV1, XDH | 5.31699 |
| [MF] GO:0016836 | hydro-lyase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 5.19586 |
| [MF] GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2, TBXAS1, TYR | 5.15692 |
| [MF] GO:0036094 | small molecule binding | ABCB1, ABCG2, ADORA1, AOX1, AURKB, AXL, CDK6, CSNK2A1, DNMT1, DYRK1A, EGFR, FABP3, FABP4, FLT3, HMGCR, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, POLA1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SLC1A1, SRC, TEK, TOP2A, TRPV1, XDH | 5.06725 |
| [MF] GO:0019899 | enzyme binding | ADORA2A, ADRB1, ADRB2, APP, AURKB, BACE1, BCL2, CDC25B, CYP1A1, CYP1A2, CYP2A6, DUSP3, EGFR, ESR1, ESR2, ESRRB, F3, GRM5, HMGCR, HSPA1A, MET, MIF, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS2, TOP2A | 4.9913 |
| [MF] GO:0000166 | nucleotide binding | ABCB1, ABCG2, AOX1, AURKB, AXL, CDK6, CSNK2A1, DNMT1, DYRK1A, EGFR, FLT3, HMGCR, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, POLA1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK, TOP2A, TRPV1, XDH | 4.91605 |
| [MF] GO:1901265 | nucleoside phosphate binding | ABCB1, ABCG2, AOX1, AURKB, AXL, CDK6, CSNK2A1, DNMT1, DYRK1A, EGFR, FLT3, HMGCR, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, POLA1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK, TOP2A, TRPV1, XDH | 4.91387 |
| [MF] GO:0015238 | None | ABCB1, ABCG2, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2 | 4.79931 |
| [MF] GO:0004497 | monooxygenase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1, TYR | 4.76835 |
| [MF] GO:1901363 | heterocyclic compound binding | ABCB1, ABCG2, ADORA1, AOX1, APEX1, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HMGCR, HSD11B2, HSD17B1, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IGF1R, INSR, KDR, MET, MMP12, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TBXAS1, TEK, TERT, TOP2A, TRPV1, XDH | 4.74855 |
| [MF] GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | AKR1B1, AKR1B10, AOX1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH | 4.65116 |
| [MF] GO:0070330 | aromatase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 | 4.57609 |
| [MF] GO:0016829 | lyase activity | APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1, POLB | 4.54103 |
| [MF] GO:0042802 | identical protein binding | ABCG2, ACHE, ADORA2A, ADRB2, AOX1, APP, BCL2, CSNK2A1, DYRK1A, EGFR, ESR1, ESR2, FLT3, GRIK5, HMGCR, IGF1R, KDR, MET, MIF, MMP9, NQO2, PTGS2, SLC22A1, SMAD3, TERT, TOP2A, TRPV1, TYR, XDH | 4.37818 |
| [MF] GO:0098531 | transcription factor activity, direct ligand regulated sequence-specific DNA binding | ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC | 4.26092 |
| [MF] GO:0004879 | nuclear receptor activity | ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC | 4.26092 |
| [MF] GO:0005524 | ATP binding | ABCB1, ABCG2, AURKB, AXL, CDK6, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK, TOP2A, TRPV1 | 4.19382 |
| [MF] GO:0004698 | None | PRKCA, PRKCB, PRKCG | 4.13323 |
| [MF] GO:0043168 | anion binding | ABCB1, ABCG2, ALOX15, AOX1, APP, AURKB, AXL, CDK6, CSNK2A1, DYRK1A, EGFR, F10, F3, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SLC1A1, SRC, TEK, TOP2A, TRPV1, XDH | 4.08143 |
| [MF] GO:0032559 | adenyl ribonucleotide binding | ABCB1, ABCG2, AURKB, AXL, CDK6, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK, TOP2A, TRPV1 | 4.02287 |
| [MF] GO:0005496 | steroid binding | ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, RORC | 4.00007 |
| [MF] GO:0030554 | adenyl nucleotide binding | ABCB1, ABCG2, AURKB, AXL, CDK6, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK, TOP2A, TRPV1 | 3.97911 |
| [MF] GO:0003707 | steroid hormone receptor activity | ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC | 3.83511 |
| [MF] GO:0016907 | None | CHRM1, CHRM2, CHRM4 | 3.78631 |
| [MF] GO:0003674 | molecular_function | ABCB1, ABCG2, ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, ADRB2, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CDK6, CES2, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SMAD3, SRC, TBXAS1, TEK, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH | 3.69683 |
| [MF] GO:0005329 | None | SLC22A1, SLC22A2, SLC22A3 | 3.5194 |
| [MF] GO:0004674 | protein serine/threonine kinase activity | AURKB, CDK6, CSNK2A1, DYRK1A, EGFR, NUAK1, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG | 3.3204 |
| [MF] GO:0001609 | None | ADORA1, ADORA2A, ADORA3 | 3.31134 |
| [MF] GO:0019825 | oxygen binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 | 3.248 |
| [MF] GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | AKR1B1, AKR1B10, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.16715 |
| [MF] GO:0032403 | protein complex binding | ACHE, ADORA1, ADRB2, APEX1, EGFR, ESRRB, FLT3, HTR2A, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, PTPN1, SMAD3, SRC | 3.06104 |
| [MF] GO:0042562 | hormone binding | ACHE, EGFR, HSD17B1, IGF1R, INSR, NQO2 | 3.01073 |
| [MF] GO:0008504 | None | SLC22A1, SLC22A2, SLC22A3 | 2.97532 |
| [MF] GO:0015651 | None | SLC22A1, SLC22A2, SLC22A3 | 2.97532 |
| [MF] GO:0004716 | signal transducer, downstream of receptor, with protein tyrosine kinase activity | EGFR, INSR, KDR | 2.97532 |
| [MF] GO:0044877 | macromolecular complex binding | ACHE, ADORA1, ADRB2, APEX1, CSNK2A1, EGFR, ESRRB, FLT3, HTR2A, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC | 2.94335 |
| [MF] GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 2.90525 |
| [MF] GO:0016229 | steroid dehydrogenase activity | HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 2.79317 |
| [MF] GO:0008289 | lipid binding | ALOX15, AXL, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA, RORC, TRPV1 | 2.77524 |
| [MF] GO:0004666 | prostaglandin-endoperoxide synthase activity | PTGS1, PTGS2 | 2.74568 |
| [MF] GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding | ESR1, ESR2 | 2.74568 |
| [MF] GO:0003845 | None | HSD11B1, HSD11B2 | 2.74568 |
| [MF] GO:0008389 | None | CYP2A13, CYP2A6 | 2.74568 |
| [MF] GO:0035403 | None | PRKCA, PRKCB | 2.74568 |
| [MF] GO:0071886 | None | HTR2A, HTR2C | 2.74568 |
| [MF] GO:0009931 | None | PRKCA, PRKCB, PRKCG | 2.73724 |
| [MF] GO:0035639 | purine ribonucleoside triphosphate binding | ABCB1, ABCG2, AURKB, AXL, CDK6, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK, TOP2A, TRPV1 | 2.73298 |
| [MF] GO:0001540 | amyloid-beta binding | ACHE, ADRB2, BACE1, GRIA2, INSR | 2.71802 |
| [MF] GO:0010857 | None | PRKCA, PRKCB, PRKCG | 2.63305 |
| [MF] GO:0008395 | steroid hydroxylase activity | CYP19A1, CYP1A1, CYP2A13, CYP2A6 | 2.55546 |
| [MF] GO:0009055 | electron transfer activity | AKR1B1, AOX1, CYP19A1, CYP1A2, NQO2, XDH | 2.51588 |
| [MF] GO:0097367 | carbohydrate derivative binding | ABCB1, ABCG2, ADORA1, APP, AURKB, AXL, CDK6, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, POLA1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK, TOP2A, TRPV1 | 2.45037 |
| [MF] GO:0032555 | purine ribonucleotide binding | ABCB1, ABCG2, AURKB, AXL, CDK6, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK, TOP2A, TRPV1 | 2.43193 |
| [MF] GO:0017076 | purine nucleotide binding | ABCB1, ABCG2, AURKB, AXL, CDK6, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK, TOP2A, TRPV1 | 2.41506 |
| [MF] GO:0032553 | ribonucleotide binding | ABCB1, ABCG2, AURKB, AXL, CDK6, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK, TOP2A, TRPV1 | 2.4107 |
| [MF] GO:0019902 | phosphatase binding | BCL2, EGFR, HMGCR, MET, PPARA, PTPN1, SMAD3 | 2.4034 |
| [MF] GO:0050473 | arachidonate 15-lipoxygenase activity | ALOX15, PTGS2 | 2.34613 |
| [MF] GO:0015307 | None | SLC47A1, SLC47A2 | 2.34613 |
| [MF] GO:1901375 | None | SLC22A1, SLC22A2 | 2.34613 |
| [MF] GO:0004949 | None | CNR1, CNR2 | 2.34613 |
| [MF] GO:0004939 | None | ADRB1, ADRB2 | 2.34613 |
| [MF] GO:0005333 | None | SLC22A1, SLC22A2 | 2.34613 |
| [MF] GO:0005277 | None | SLC22A1, SLC22A2 | 2.34613 |
| [MF] GO:0099583 | None | GRM1, GRM5 | 2.34613 |
| [MF] GO:0008513 | None | SLC22A1, SLC22A2 | 2.34613 |
| [MF] GO:0004699 | None | PRKCD, PRKCE | 2.34613 |
| [MF] GO:0140096 | catalytic activity, acting on a protein | AURKB, AXL, BACE1, CDC25B, CDK6, CSNK2A1, DUSP3, DYRK1A, EGFR, F10, F3, FLT3, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC, TEK | 2.22901 |
| [MF] GO:0035173 | histone kinase activity | AURKB, PRKCA, PRKCB | 2.22901 |
| [MF] GO:0016903 | None | AKR1B1, AKR1B10, AOX1, XDH | 2.18499 |
| [MF] GO:0046983 | protein dimerization activity | ABCG2, ACHE, ADORA1, ADORA2A, ADRB1, ADRB2, AOX1, AXL, BCL2, EGFR, FLT3, HMGCR, NQO2, PTGS2, SLC22A1, SMAD3, TERT, TOP2A, TYR, XDH | 2.16502 |
| [MF] GO:0015464 | None | CHRM1, CHRM2, CHRM4 | 2.16264 |
| [MF] GO:0042803 | protein homodimerization activity | ABCG2, ACHE, ADRB2, AOX1, BCL2, FLT3, HMGCR, NQO2, PTGS2, SLC22A1, SMAD3, TERT, TOP2A, TYR, XDH | 2.12887 |
| [MF] GO:0004970 | None | GRIA2, GRIA4, GRIK5 | 2.10464 |
| [MF] GO:0005234 | None | GRIA2, GRIA4, GRIK5 | 2.10464 |
| [MF] GO:0034056 | estrogen response element binding | ESR1, ESR2 | 2.10114 |
| [MF] GO:0004971 | None | GRIA2, GRIA4 | 2.10114 |
| [MF] GO:0051425 | None | APP, INSR | 2.10114 |
| [MF] GO:0005231 | None | GRIA2, GRIA4, GRIK5, TRPV1 | 2.06679 |
| [MF] GO:0035258 | None | ESR1, FLT3, PRKCB, SMAD3, SRC | 2.05279 |
| [MF] GO:0001223 | transcription coactivator binding | ESR1, PPARA, TERT | 2.04916 |
| KEGG Pathway ID | Enriched Genes | Log10 Adjusted P-value |
|---|---|---|
| Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | CHRM2, GRIA2, CHRM1, CHRM4, GRIK5, HTR2B, HTR2C, ADRB1, HTR2A, ADRB2, HTR4, GRM1, GRM3, HTR6, GRM5, HTR7, CNR2, CNR1, ADORA3, GRM8, ADORA1, GRIA4, HTR1E, GPR35, HTR1D, HTR1A, HTR1B, TRPV1, HTR5A, ADORA2A | 25.6119 |
| Serotonergic synapse_Homo sapiens_hsa04726 | PRKCG, APP, HTR1E, PRKCB, ALOX15, HTR1D, HTR2B, HTR1A, HTR1B, HTR2C, PRKCA, HTR2A, PTGS2, HTR5A, HTR4, PTGS1, HTR6, HTR7, ALOX5 | 19.4424 |
| Calcium signaling pathway_Homo sapiens_hsa04020 | CHRM2, PRKCG, CHRM1, PRKCB, HTR2B, HTR2C, PRKCA, ADRB1, HTR2A, ADRB2, HTR5A, HTR4, GRM1, EGFR, HTR6, GRM5, HTR7, ADORA2A | 14.2528 |
| cAMP signaling pathway_Homo sapiens_hsa04024 | CHRM2, GRIA2, CHRM1, HTR1E, HTR1D, HTR1A, HTR1B, ADRB1, PIK3CB, ADRB2, HTR4, HCAR2, HTR6, ADORA2A, PIK3CA, ADORA1, PPARA, GRIA4 | 13.5988 |
| Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | PRKCG, PIK3CA, PRKCB, SRC, PRKCE, PRKCD, HTR2B, HTR2C, PRKCA, PIK3CB, TRPV1, HTR2A | 10.3076 |
| AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | SMAD3, PIK3CA, PRKCB, MMP2, PRKCE, PRKCD, BCL2, PIM1, PRKCA, PIK3CB, F3 | 9.0903 |
| Ovarian steroidogenesis_Homo sapiens_hsa04913 | ALOX5, INSR, HSD17B1, HSD17B2, CYP1A1, CYP1B1, PTGS2, CYP19A1, IGF1R | 9.2205 |
| Gap junction_Homo sapiens_hsa04540 | PRKCG, GRM5, PRKCB, SRC, HTR2B, HTR2C, PRKCA, ADRB1, HTR2A, GRM1, EGFR | 9.6014 |
| Estrogen signaling pathway_Homo sapiens_hsa04915 | PIK3CA, SRC, MMP2, PRKCD, PIK3CB, MMP9, ESR1, GRM1, EGFR, ESR2, HSPA1A | 9.1406 |
| MicroRNAs in cancer_Homo sapiens_hsa05206 | PRKCG, DNMT1, ABCB1, PRKCB, PRKCE, PRKCA, PTGS2, MMP9, EGFR, CDC25B, CDK6, PIK3CA, BCL2, PIM1, CYP1B1, MET | 8.9626 |
| Rap1 signaling pathway_Homo sapiens_hsa04015 | PRKCG, PRKCB, SRC, INSR, PRKCA, PIK3CB, EGFR, IGF1R, ADORA2A, PIK3CA, CNR1, KDR, TEK, MET | 8.9626 |
| Glutamatergic synapse_Homo sapiens_hsa04724 | GRM3, PRKCG, GRIA2, GRM5, PRKCB, GRIK5, GRM8, SLC1A1, PRKCA, GRM1, GRIA4 | 8.6594 |
| Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | FABP4, PIK3CA, INSR, ADORA1, ADRB1, PIK3CB, ADRB2, PTGS2, PTGS1 | 8.9626 |
| Proteoglycans in cancer_Homo sapiens_hsa05205 | PRKCG, PRKCB, SRC, MMP2, PRKCA, PIK3CB, MMP9, ESR1, EGFR, IGF1R, PIK3CA, KDR, MET | 8.1417 |
| Cholinergic synapse_Homo sapiens_hsa04725 | CHRM2, PRKCG, ACHE, CHRM1, PIK3CA, PRKCB, CHRM4, BCL2, PRKCA, PIK3CB | 7.6028 |
| Pathways in cancer_Homo sapiens_hsa05200 | PRKCG, SMAD3, PRKCB, FLT3, MMP1, MMP2, PRKCA, PIK3CB, PTGS2, MMP9, EGFR, IGF1R, CDK6, PIK3CA, BCL2, MET | 7.3695 |
| HIF-1 signaling pathway_Homo sapiens_hsa04066 | PRKCG, PIK3CA, PRKCB, INSR, BCL2, PRKCA, TEK, PIK3CB, EGFR, IGF1R | 7.8972 |
| Nitrogen metabolism_Homo sapiens_hsa00910 | CA12, CA1, CA2, CA4, CA7, CA9, CA14 | 9.6866 |
| VEGF signaling pathway_Homo sapiens_hsa04370 | PRKCG, PIK3CA, PRKCB, SRC, KDR, PRKCA, PIK3CB, PTGS2 | 7.3695 |
| Glioma_Homo sapiens_hsa05214 | PRKCG, CDK6, PIK3CA, PRKCB, PRKCA, PIK3CB, EGFR, IGF1R | 7.1667 |
| Ras signaling pathway_Homo sapiens_hsa04014 | PRKCG, HTR7, PIK3CA, PRKCB, INSR, KDR, PRKCA, TEK, PIK3CB, MET, EGFR, IGF1R | 6.7688 |
| Choline metabolism in cancer_Homo sapiens_hsa05231 | PRKCG, SLC22A3, PIK3CA, PRKCB, SLC22A2, SLC22A1, PRKCA, PIK3CB, EGFR | 6.8945 |
| Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | PRKCG, GRIA2, GRM5, PRKCB, CNR1, PRKCA, PTGS2, GRM1, GRIA4 | 6.8945 |
| Hepatitis B_Homo sapiens_hsa05161 | PRKCG, CDK6, SMAD3, PIK3CA, PRKCB, SRC, BCL2, PRKCA, PIK3CB, MMP9 | 6.6499 |
| Steroid hormone biosynthesis_Homo sapiens_hsa00140 | HSD11B1, HSD11B2, HSD17B1, HSD17B2, CYP1A2, CYP1A1, CYP1B1, CYP19A1 | 7.484 |
| Focal adhesion_Homo sapiens_hsa04510 | PRKCG, PIK3CA, PRKCB, SRC, KDR, BCL2, PRKCA, PIK3CB, MET, EGFR, IGF1R | 6.3508 |
| PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | CHRM2, CHRM1, INSR, PRKCA, PIK3CB, EGFR, IGF1R, CDK6, PIK3CA, KDR, BCL2, TEK, MET | 5.7783 |
| Adherens junction_Homo sapiens_hsa04520 | PTPN1, SMAD3, CSNK2A1, SRC, INSR, MET, EGFR, IGF1R | 6.7688 |
| Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | PRKCG, HSD11B2, PIK3CA, PRKCB, INSR, PRKCA, PIK3CB | 7.3695 |
| Sphingolipid signaling pathway_Homo sapiens_hsa04071 | PRKCG, PIK3CA, PRKCB, ADORA3, PRKCE, BCL2, ADORA1, PRKCA, PIK3CB | 6.3358 |
| Phospholipase D signaling pathway_Homo sapiens_hsa04072 | GRM3, GRM5, PIK3CA, INSR, GRM8, PRKCA, PIK3CB, GRM1, EGFR | 5.684 |
| Non-small cell lung cancer_Homo sapiens_hsa05223 | PRKCG, CDK6, PIK3CA, PRKCB, PRKCA, PIK3CB, EGFR | 6.3683 |
| Insulin resistance_Homo sapiens_hsa04931 | PTPN1, PIK3CA, PRKCB, INSR, PRKCE, PRKCD, PIK3CB, PPARA | 5.5674 |
| Metabolic pathways_Homo sapiens_hsa01100 | DNMT1, ALOX15, AKR1B1, HMGCR, PTGS2, TYR, GBA2, CYP19A1, PTGS1, HSD11B1, POLA1, CYP2A6, FUT7, AKR1B10, ALOX5, HSD17B1, TBXAS1, HSD17B2, CYP1A2, CYP1A1, AOX1, ALPL, XDH | 4.8286 |
| ErbB signaling pathway_Homo sapiens_hsa04012 | PRKCG, PIK3CA, PRKCB, SRC, PRKCA, PIK3CB, EGFR | 5.1345 |
| Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | PRKCG, PIK3CA, PRKCB, PRKCE, PRKCD, PRKCA, PIK3CB | 4.9504 |
| Oxytocin signaling pathway_Homo sapiens_hsa04921 | PRKCG, PIK3CA, PRKCB, SRC, PRKCA, PIK3CB, PTGS2, EGFR | 4.479 |
| Chemical carcinogenesis_Homo sapiens_hsa05204 | HSD11B1, CYP2A6, CYP2A13, CYP1A2, CYP1A1, CYP1B1, PTGS2 | 5.2972 |
| cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | PIK3CA, ADORA3, INSR, PRKCE, ADORA1, ADRB1, PIK3CB, ADRB2 | 4.3315 |
| Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | PRKCG, PIK3CA, PRKCB, SRC, PRKCA, PIK3CB, ESR1 | 4.3685 |
| Long-term depression_Homo sapiens_hsa04730 | PRKCG, GRIA2, PRKCB, PRKCA, GRM1, IGF1R | 4.9469 |
| Melanoma_Homo sapiens_hsa05218 | CDK6, PIK3CA, PIK3CB, MET, EGFR, IGF1R | 4.5699 |
| Endocytosis_Homo sapiens_hsa04144 | SMAD3, SRC, KDR, ADRB1, ADRB2, MET, EGFR, IGF1R, HSPA1A | 3.8242 |
| Leukocyte transendothelial migration_Homo sapiens_hsa04670 | PRKCG, PIK3CA, PRKCB, MMP2, PRKCA, PIK3CB, MMP9 | 4.3685 |
| FoxO signaling pathway_Homo sapiens_hsa04068 | SMAD3, PIK3CA, INSR, PIK3CB, GRM1, EGFR, IGF1R | 4.0572 |
| Long-term potentiation_Homo sapiens_hsa04720 | PRKCG, GRIA2, GRM5, PRKCB, PRKCA, GRM1 | 4.7352 |
| GnRH signaling pathway_Homo sapiens_hsa04912 | PRKCB, SRC, MMP2, PRKCD, PRKCA, EGFR | 4.0229 |
| Tight junction_Homo sapiens_hsa04530 | PRKCG, CSNK2A1, PRKCB, SRC, PRKCE, PRKCD, PRKCA | 3.9512 |
| Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | HSD11B1, CYP2A6, CYP2A13, CYP1A2, CYP1A1, CYP1B1 | 4.5098 |
| Vascular smooth muscle contraction_Homo sapiens_hsa04270 | PRKCG, ADORA2A, PRKCB, PRKCE, PRKCD, PRKCA | 3.4391 |
| Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | CHRM2, CHRM1, PIK3CA, SRC, CHRM4, PIK3CB, EGFR | 2.9314 |
| Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | PIK3CA, BCL2, PRKCA, ADRB1, PIK3CB, ADRB2 | 2.9948 |
| mTOR signaling pathway_Homo sapiens_hsa04150 | PRKCG, PIK3CA, PRKCB, PRKCA, PIK3CB | 3.8419 |
| Taste transduction_Homo sapiens_hsa04742 | HTR1E, HTR1D, HTR1A, HTR1B, GRM1 | 3.2502 |
| Prostate cancer_Homo sapiens_hsa05215 | PIK3CA, BCL2, PIK3CB, EGFR, IGF1R | 3.1348 |
| Circadian entrainment_Homo sapiens_hsa04713 | PRKCG, GRIA2, PRKCB, PRKCA, GRIA4 | 3.0096 |
| Prolactin signaling pathway_Homo sapiens_hsa04917 | PIK3CA, SRC, PIK3CB, ESR1, ESR2 | 3.5219 |
| Pancreatic cancer_Homo sapiens_hsa05212 | CDK6, SMAD3, PIK3CA, PIK3CB, EGFR | 3.6735 |
| MAPK signaling pathway_Homo sapiens_hsa04010 | PRKCG, DUSP3, PRKCB, PRKCA, EGFR, CDC25B, HSPA1A | 2.5394 |
| Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | PIK3CA, INSR, PIK3CB, IGF1R, HSPA1A | 3.73 |
| Amphetamine addiction_Homo sapiens_hsa05031 | PRKCG, GRIA2, PRKCB, PRKCA, GRIA4 | 3.6572 |
| Small cell lung cancer_Homo sapiens_hsa05222 | CDK6, PIK3CA, BCL2, PIK3CB, PTGS2 | 3.1846 |
| Central carbon metabolism in cancer_Homo sapiens_hsa05230 | PIK3CA, FLT3, PIK3CB, MET, EGFR | 3.6572 |
| Platelet activation_Homo sapiens_hsa04611 | PIK3CA, SRC, TBXAS1, PIK3CB, PTGS1 | 2.5746 |
| Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | PRKCG, PIK3CA, PRKCB, PRKCA, PIK3CB | 2.9598 |
| Salivary secretion_Homo sapiens_hsa04970 | PRKCG, PRKCB, PRKCA, ADRB1, ADRB2 | 3.1348 |
| Amoebiasis_Homo sapiens_hsa05146 | PRKCG, PIK3CA, PRKCB, PRKCA, PIK3CB | 2.9314 |
| Huntington's disease_Homo sapiens_hsa05016 | GRM5 | 0.1492 |
| Herpes simplex infection_Homo sapiens_hsa05168 | CSNK2A1 | 0.1564 |
| Alcoholism_Homo sapiens_hsa05034 | ADORA2A | 0.1617 |
| Toxoplasmosis_Homo sapiens_hsa05145 | PIK3CA, ALOX5, BCL2, PIK3CB, HSPA1A | 2.6282 |
| Hippo signaling pathway_Homo sapiens_hsa04390 | SMAD3 | 0.1978 |
| Parkinson's disease_Homo sapiens_hsa05012 | ADORA2A | 0.2151 |
| AMPK signaling pathway_Homo sapiens_hsa04152 | PIK3CA, INSR, PIK3CB, HMGCR, IGF1R | 2.5487 |
| Spliceosome_Homo sapiens_hsa03040 | HSPA1A | 0.2285 |
| Axon guidance_Homo sapiens_hsa04360 | MET | 0.2411 |
| Bile secretion_Homo sapiens_hsa04976 | ABCB1, CA2, SLC22A1, HMGCR, ABCG2 | 3.5436 |
| Oocyte meiosis_Homo sapiens_hsa04114 | IGF1R | 0.2479 |
| Dopaminergic synapse_Homo sapiens_hsa04728 | PRKCG, GRIA2, PRKCB, PRKCA, GRIA4 | 2.5011 |
| Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | PRKCG, PIK3CA, PRKCB, PRKCA, PIK3CB | 2.427 |
| Pyrimidine metabolism_Homo sapiens_hsa00240 | POLA1 | 0.2923 |
| Bladder cancer_Homo sapiens_hsa05219 | SRC, MMP1, MMP2, MMP9, EGFR | 4.5699 |
| Measles_Homo sapiens_hsa05162 | CDK6, CSNK2A1, PIK3CA, PIK3CB, HSPA1A | 2.4229 |
| Glucagon signaling pathway_Homo sapiens_hsa04922 | PPARA | 0.3019 |
| Arachidonic acid metabolism_Homo sapiens_hsa00590 | ALOX5, ALOX15, TBXAS1, PTGS2, PTGS1 | 3.7889 |
| Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | SMAD3, PIK3CA, ESRRB, PIK3CB, IGF1R | 2.3505 |
| Wnt signaling pathway_Homo sapiens_hsa04310 | PRKCG, SMAD3, CSNK2A1, PRKCB, PRKCA | 2.3505 |
| Glycerophospholipid metabolism_Homo sapiens_hsa00564 | ACHE | 0.3187 |
| Purine metabolism_Homo sapiens_hsa00230 | POLA1, XDH | 0.4584 |
| Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | BCL2, HSPA1A | 0.4743 |
| Tuberculosis_Homo sapiens_hsa05152 | SRC, BCL2 | 0.4544 |
| Alzheimer's disease_Homo sapiens_hsa05010 | BACE1, APP | 0.4752 |
| Hematopoietic cell lineage_Homo sapiens_hsa04640 | FLT3 | 0.3336 |
| Dilated cardiomyopathy_Homo sapiens_hsa05414 | ADRB1 | 0.3336 |
| Protein digestion and absorption_Homo sapiens_hsa04974 | SLC1A1 | 0.3336 |
| TGF-beta signaling pathway_Homo sapiens_hsa04350 | SMAD3 | 0.3462 |
| Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | CSNK2A1 | 0.3336 |
| Type II diabetes mellitus_Homo sapiens_hsa04930 | PIK3CA, INSR, PRKCE, PRKCD, PIK3CB | 4.2844 |
| Peroxisome_Homo sapiens_hsa04146 | XDH | 0.3477 |
| Jak-STAT signaling pathway_Homo sapiens_hsa04630 | PIK3CA, BCL2, PIM1, AOX1, PIK3CB | 2.1869 |
| Osteoclast differentiation_Homo sapiens_hsa04380 | PIK3CA, PIK3CB | 0.6052 |
| Influenza A_Homo sapiens_hsa05164 | PIK3CA, PRKCB, PRKCA, PIK3CB, HSPA1A | 2.0164 |
| Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | FLT3, KDR, MET, EGFR | 0.9226 |
| Antigen processing and presentation_Homo sapiens_hsa04612 | HSPA1A | 0.3702 |
| Epstein-Barr virus infection_Homo sapiens_hsa05169 | CSNK2A1, PIK3CA, BCL2, PIK3CB, HSPA1A | 1.7962 |
| Chemokine signaling pathway_Homo sapiens_hsa04062 | PIK3CA, PRKCB, SRC, PRKCD, PIK3CB | 1.9052 |
| Adipocytokine signaling pathway_Homo sapiens_hsa04920 | PPARA | 0.4001 |
| Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | PIK3CA, PIK3CB | 0.7277 |
| Viral carcinogenesis_Homo sapiens_hsa05203 | POLB, CDK6, PIK3CA, SRC, PIK3CB | 1.7781 |
| T cell receptor signaling pathway_Homo sapiens_hsa04660 | PIK3CA, PIK3CB | 0.7378 |
| Apoptosis_Homo sapiens_hsa04210 | PIK3CA, BCL2, PIK3CB | 1.0777 |
| p53 signaling pathway_Homo sapiens_hsa04115 | CDK6 | 0.4026 |
| Chronic myeloid leukemia_Homo sapiens_hsa05220 | CDK6, SMAD3, PIK3CA, PIK3CB | 2.5439 |
| HTLV-I infection_Homo sapiens_hsa05166 | POLB, SMAD3, PIK3CA, TERT, PIK3CB | 1.4318 |
| Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | FLT3, MMP9, MET, IGF1R | 1.3828 |
| Neurotrophin signaling pathway_Homo sapiens_hsa04722 | PIK3CA, PRKCD, BCL2, PIK3CB | 1.8874 |
| TNF signaling pathway_Homo sapiens_hsa04668 | PIK3CA, PIK3CB, PTGS2, MMP9 | 2.0114 |
| Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | PIK3CA, PIK3CB, CDC25B, IGF1R | 2.1727 |
| Shigellosis_Homo sapiens_hsa05131 | SRC | 0.4209 |
| Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | PIK3CA, INSR, PIK3CB, PPARA | 1.6061 |
| Morphine addiction_Homo sapiens_hsa05032 | PRKCG, PRKCB, ADORA1, PRKCA | 2.2573 |
| Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | PIK3CA, INSR, PIK3CB, IGF1R | 2.2201 |
| Insulin signaling pathway_Homo sapiens_hsa04910 | PTPN1, PIK3CA, INSR, PIK3CB | 1.7156 |
| Melanogenesis_Homo sapiens_hsa04916 | PRKCG, PRKCB, PRKCA, TYR | 2.1456 |
| Hepatitis C_Homo sapiens_hsa05160 | PIK3CA, PIK3CB, PPARA, EGFR | 1.7693 |
| Cell cycle_Homo sapiens_hsa04110 | CDK6, SMAD3, CDC25B | 1.1995 |
| Gastric acid secretion_Homo sapiens_hsa04971 | PRKCG, PRKCB, CA2, PRKCA | 2.5327 |
| Rheumatoid arthritis_Homo sapiens_hsa05323 | MMP1, TEK | 0.8339 |
| Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | PRKCG, PRKCB, PRKCE, PRKCA | 2.4229 |
| NF-kappa B signaling pathway_Homo sapiens_hsa04064 | CSNK2A1, PRKCB, BCL2, PTGS2 | 2.2323 |
| GABAergic synapse_Homo sapiens_hsa04727 | PRKCG, PRKCB, SRC, PRKCA | 2.3055 |
| Pancreatic secretion_Homo sapiens_hsa04972 | PRKCG, PRKCB, CA2, PRKCA | 2.1961 |
| Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | PIK3CA, SRC, PIK3CB, MET | 2.4685 |
| Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | SMAD3, PIK3CA, PIK3CB | 1.375 |
| PPAR signaling pathway_Homo sapiens_hsa03320 | FABP3, FABP4, MMP1, PPARA | 2.6189 |
| Legionellosis_Homo sapiens_hsa05134 | HSPA1A | 0.4728 |
| Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | PRKCA | 0.4728 |
| Retinol metabolism_Homo sapiens_hsa00830 | CYP2A6, CYP1A2, CYP1A1, AOX1 | 2.7051 |
| Colorectal cancer_Homo sapiens_hsa05210 | SMAD3, PIK3CA, BCL2, PIK3CB | 2.777 |
| Complement and coagulation cascades_Homo sapiens_hsa04610 | F10, F3 | 0.9197 |
| Vibrio cholerae infection_Homo sapiens_hsa05110 | PRKCA | 0.4899 |
| Leishmaniasis_Homo sapiens_hsa05140 | PRKCB, PTGS2 | 0.969 |
| Acute myeloid leukemia_Homo sapiens_hsa05221 | PIK3CA, FLT3, PIM1, PIK3CB | 2.9104 |
| Malaria_Homo sapiens_hsa05144 | MET | 0.502 |
| Inositol phosphate metabolism_Homo sapiens_hsa00562 | PIK3CA, PIK3CB | 0.9867 |
| Insulin secretion_Homo sapiens_hsa04911 | PRKCG, PRKCB, PRKCA | 1.5791 |
| Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | AOX1 | 0.507 |
| Sphingolipid metabolism_Homo sapiens_hsa00600 | GBA2 | 0.512 |
| B cell receptor signaling pathway_Homo sapiens_hsa04662 | PIK3CA, PRKCB, PIK3CB | 1.738 |
| Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | PIK3CA, PRKCA, PIK3CB | 1.7989 |
| Cysteine and methionine metabolism_Homo sapiens_hsa00270 | DNMT1 | 0.5256 |
| Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | SMAD3, RORC | 1.0503 |
| Renal cell carcinoma_Homo sapiens_hsa05211 | PIK3CA, PIK3CB, MET | 1.8225 |
| Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | PRKCG, PRKCB, PRKCA, ESR1 | 3.1842 |
| Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | SRC, MET, EGFR | 1.7989 |
| Thyroid hormone synthesis_Homo sapiens_hsa04918 | PRKCG, PRKCB, PRKCA | 1.767 |
| Renin secretion_Homo sapiens_hsa04924 | ADORA1, ADRB1, ADRB2 | 1.8551 |
| Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | CYP2A6, CYP1A2, AOX1 | 1.7894 |
| Glycerolipid metabolism_Homo sapiens_hsa00561 | AKR1B10, AKR1B1 | 1.1181 |
| Pyruvate metabolism_Homo sapiens_hsa00620 | GLO1 | 0.5675 |
| Prion diseases_Homo sapiens_hsa05020 | HSPA1A | 0.6105 |
| Endometrial cancer_Homo sapiens_hsa05213 | PIK3CA, PIK3CB, EGFR | 2.0859 |
| Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | GRIA2, BCL2 | 1.2253 |
| DNA replication_Homo sapiens_hsa03030 | POLA1 | 0.6052 |
| Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | FUT7 | 0.6552 |
| Cocaine addiction_Homo sapiens_hsa05030 | GRM3, GRIA2 | 1.2535 |
| Dorso-ventral axis formation_Homo sapiens_hsa04320 | EGFR | 0.7014 |
| Tryptophan metabolism_Homo sapiens_hsa00380 | CYP1A2, CYP1A1, AOX1, CYP1B1 | 3.4391 |
| Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | PIK3CA, PRKCB, PIK3CB | 2.2323 |
| Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | AOX1 | 0.6757 |
| ABC transporters_Homo sapiens_hsa02010 | ABCB1, ABCG2 | 1.3325 |
| Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | FUT7 | 0.7104 |
| Drug metabolism - other enzymes_Homo sapiens_hsa00983 | CYP2A6, XDH, CES2 | 2.2152 |
| Circadian rhythm_Homo sapiens_hsa04710 | RORC | 0.6651 |
| Nicotine addiction_Homo sapiens_hsa05033 | GRIA2, GRIA4 | 1.3991 |
| Collecting duct acid secretion_Homo sapiens_hsa04966 | CA2 | 0.7014 |
| African trypanosomiasis_Homo sapiens_hsa05143 | PRKCG, PRKCB, PRKCA | 2.5011 |
| Galactose metabolism_Homo sapiens_hsa00052 | AKR1B10, AKR1B1 | 1.6103 |
| Tyrosine metabolism_Homo sapiens_hsa00350 | AOX1, MIF, TYR | 2.5011 |
| Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | AKR1B10, AKR1B1 | 1.4778 |
| Base excision repair_Homo sapiens_hsa03410 | POLB, APEX1 | 1.5458 |
| Fructose and mannose metabolism_Homo sapiens_hsa00051 | AKR1B10, AKR1B1 | 1.5675 |
| Linoleic acid metabolism_Homo sapiens_hsa00591 | ALOX15, CYP1A2 | 1.6347 |
| Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | HMGCR | 0.7688 |
| Phenylalanine metabolism_Homo sapiens_hsa00360 | MIF | 0.8652 |
| Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | CA2, CA4 | 1.7989 |
| Other glycan degradation_Homo sapiens_hsa00511 | GBA2 | 0.8447 |
| Folate biosynthesis_Homo sapiens_hsa00790 | ALPL | 0.9363 |
| Vitamin B6 metabolism_Homo sapiens_hsa00750 | AOX1 | 1.2644 |
| Caffeine metabolism_Homo sapiens_hsa00232 | CYP2A6, CYP1A2, XDH | 4.9069 |